Appendix — Bluestein v. Skinner

Supreme Court brief1991

Ask Donna

What actually matters in this document.

Text

IN THE

Supreme Court of the Buited States

OCTOBER TERM, 1990

MICHAEL §. BLUESTEIN, et al.,

Petitioners,

Vv.

SAMUEL K. SKINNER,

Secretary of Transportation, et al.,

Respondents.

Petition for a Writ of Certiorari to the

United States Court of Appeals

for the Ninth Circuit

APPENDIX TO

PETITION FOR. A WRIT OF CERTIORARI

WALTER KAMIAT

LAURENCE GOLD

(Counsel of Record)

815 16th Street, N.W.

Washington, D.C. 20006

(202) 637-5390

[Attorneys for Individual Petitioners Listed on Inside Cover]

WILSON - EPES PRINTING Co., INC. - 789-0096 - WASHINGTON, D.C. 20001

@ ES» co

1 tite

GARY GREEN

JERRY ANKER

1625 Massachusetts Ave., N.W.

Washington, D.C. 20036

Counsel for Air Line Pilots

Association

WILLIAM JOLLEY

204 West Linwood Boulevard

Kansas City, MO 64111

Counsel for Sheri Albert,

Charles McCune and

Independent Federation of

Flight Attendants

DEBORAH GREENFIELD

EDWARD J. GILMARTIN

1625 Massachusetts Ave., N.W.

Washington, D.C. 20036

Counsel for Association of

Flight Attendants

MICHAEL GOTTESMAN

GEORGE COHEN

Mapy GILSON

1000 Connecticut Ave., N.W.

Washington, D.C. 20036

Counsel for Association of

Professional Flight

Attendants and Independent

Union of Flight Attendants

STEPHEN P. BERZON

FRED H. ALTSHULER

MICHAEL RUBIN

177 Post Street, Suite 300

San Francisco, CA 94108

Counsel for Michael S. Bluestein

and Dean N. Chantiles

ALLISON BECK

OWEN HERRNSTADT

1300 Connecticut Ave., N.W.

Washington, D.C. 20036

Counsel for International

Association of Machinists and

Aerospace Workers

JAMES T. GRADY

GaArY S. WITLIN

25 Louisiana Avenue, N.W.

Washington, D.C. 20001

Counsel for International

Brotherhood of Teamsters,

Chauffeurs, Warehousemen

and Helpers of America

LEE SEHAM

485 Madison Avenue

New York, NY 10022

Counsel for Richard S. Linn

Scott D. RAPHAEL

1900 Avenue of the Stars

Suite 2300

Los Angeles, CA 90067

Counsel for Orange County

Airport Association

ARTHUR M. LUBY

1300 L Street, N.W.

Washington, D.C. 20001

Counsel for Transport

Workers Union of America

LARRY MANN

400 First Street, N.W.

Washington, D.C. 20001

Counsel for Transportation-

Communications International

Union

TABLE OF CONTENTS

APPENDIX A Page

Opinion of the United States Court of Appeals for

the Ninth Circuit in Michael S. Bluestein, et al. v.

Samuel K. Skinner, Secretary of Transportation,

et al., 908 F.2d 451 (July 10, 1990) 00000. la

APPENDIX B

Federal Aviation Administration, Anti-Drug Pro-

gram for Personnel Engaged in Specified Aviation

Activities; Final Rule, 58 Fed. Reg. 47024 (No-

I epee ns 16a

la

APPENDIX A

UNITED STATES COURT OF APPEALS

NINTH CIRCUIT

Nos. 88-7503, 88-7508, 89-70024,

89-70111, 89-70138 and 88-70139

MICHAEL S. BLUESTEIN; DEAN N. CHANTILES;

ORANGE COUNTY AIRPORT ASSOCIATION,

Petitioners,

v.

SAMUEL K. SKINNER, Secretary of Transportation,

DEPARTMENT OF TRANSPORTATION,

FEDERAL AVIATION ADMINISTRATION,

Respondents.

RICHARD §. LINN,

Petitioner,

v.

SAMUEL K. SKINNER, Secretary of Transportation,

DEPARTMENT OF TRANSPORTATION,

FEDERAL AVIATION ADMINISTRATION,

Respondents.

SHERI ALBERT; CHARLES MCCUNE,

Petitioners,

v.

SAMUEL K, SKINNER, Secretary of Transportation,

DEPARTMENT OF TRANSPORTATION,

FEDERAL AVIATION ADMINISTRATION,

Respondents.

2a

ASSOCIATION OF PROFESSIONAL FLIGHT ATTENDANTS,

Petitioner,

Vv.

SAMUEL K. SKINNER, Secretary of Transportation,

DEPARTMENT OF TRANSPORTATION,

FEDERAL AVIATION ADMINISTRATION,

Respondents.

INDEPENDENT UNION OF FLIGHT ATTENDANTS,

Petitioner,

V.

FEDERAL AVIATION ADMINISTRATION,

Respondent.

AIRLINE PILOTS ASSOCIATION, INTERNATIONAL,

Petitioner,

V.

FEDERAL AVIATION ADMINISTRATION,

Respondent.

Petition for Review of an Order of the

Federal Aviation Administration

Argued and Submitted Sept. 15, 1989

Decided July 10, 1990

D0 ee il aT Oe

8a

Walter Kamiat and Laurence Gold, Washington, D.C.,

for the Air Line Pilots Ass’n, Ass’n of Flight Attendants,

Intern. Ass’n of Machinists and Aerospace Workers,

Intern. Brotherhood of Teamsters, Chauffeurs, Warehouse-

men and Helpers of America, Transp.-Communications

Intern. Union.

Gary Green and Jerry Anker, Washington, D.C., for

the Air Line Pilots Ass’n.

Stephen P. Berzon, Fred H. Altshuler, and Michael

Rubin, Altshuler & Berzon, San Francisco, Cal., Seott D.

Raphael, Newport Beach, Cal., for Michael S. Bluestein,

Dean N. Chantiles, and Orange County Airport Ass’n.

Deborah Greenfield, Matthew Finucane, and Edward

Gilmartin, Washington, D.C., for the Ass’n of Flight

Attendants.

Allison Beck, Washington, D.C., for the Intern. Ass’n

of Machinists and Aerospace Workers.

James T. Grady and Wilma B. Liebman, Washington,

D.C., for the Intern. Brotherhood of Teamsters, Chauf-

feurs, Warehousemen and Helpers of America.

David Rosen and Arthur M. Luby, Washington, D.C.,

for the Transport Workers of America.

Larry Mann, Washington, D.C., for the Transp.-

Communications Intern. Union.

Lee Seham, Seham, Klein & Zelman, New York City,

Law Offices of Thornton C. Bunch, Jr., San Francisco,

Cal., for Richard S. Linn.

Stewart Weinberg, Van Bourg, Weinberg, Roger &

Rosenfeld, San Francisco, Cal., David J. Aronofsky, Arent

Fox, Kintner, Plotkin & Kahn, Washington, D.C., William

Jolley, Jolley, Walsh, Hager & Gordon, Kansas City, Mo.,

for Sheri Albert, Charles McCune, Independent Federa-

tion of Flight Attendants.

4a

Michael Gottesman, George Cohen, and Mady Gilson,

Bredhoff & Kaiser, Washington, D.C., for the Ass’n of

Professional Flight Attendants and Independent Union

of Flight Attendants.

Diane Liff, Gen. Counsel’s Office, Dept. of Transp.,

Robert V. Zener and Leonard Schaitman, Dept. of Justice,

Civ. Div., Washington, D.C., Kenneth W. Starr, Sol. Gen.,

Washington, D.C., for respondents.

Before CHAMBERS, CANBY and NORRIS, Circuit

Judges.

WILLIAM A. NORRIS, Circuit Judge:

This is a petition for review of Federal Aviation Ad-

ministration (FAA) regulations requiring random drug

testing of flight crew members, maintenance personnel,

air traffic controllers, and several other categories of

employees in the private commercial aviation industry.

Petitioners argue that the regulations violate the Fourth

Amendment and are arbitrary and capricious in violation

of §10(e) of the Administrative Procedure Act, 5 U.S.C.

§ 706(2) (A). We reject both of petitioners’ arguments

and uphold the regulations.

I. BACKGROUND

A. The Regulations

The FAA initially proposed random drug testing in an

advance notice of proposed rule making. 51 Fed.Reg.

44432 (Dec. 9, 1986). After receiving over 650 written

comments, the FAA issued a notice of proposed rule-

making. 53 Fed.Reg. 8368 -(March 14, 1988). Over 260

written comments were filed in response to this notice,

and the FAA also held a series of public hearings. The

final rule was issued on November 21, 1988. 53 Fed.Reg.

47024.

The FAA concluded that while drug use is not “wide-

spread” among commercial aviation personnel and there

++ intial

5a

is no “overwhelming” drug problem in the industry,

nevertheless the record “does show concrete evidence of

drug use in the commercial aviation sector.” 53 Fed.Reg.

47029, 47930. Accordingly, the FAA decided that “[i]n

order to ensure that aviation safety is not compromised

by a failure to detect drug users in the aviation industry,

the FAA believes that it is appropriate and necessary to

establish a comprehensive anti-drug program at this

time.” 53 Fed.Reg. 47025.

The regulations adopted by the FAA require employee

drug testing to be performed by every Part 121 and 135

certificate holder (generally, commercial air carriers,

both scheduled and unscheduled, carrying passengers or

cargo’), as well as each air traffic control facility.2 53

Fed.Reg. 47057-58 (App. I—definition of “employer’’).

The following employees must be tested: (a) flight crew

members; (b) flight attendants; (c) flight instructors or

ground instructors; (d) flight testing personnel; (e) air-

craft dispatchers; (f) maintenance personnel; (g) avia-

tion security or screening personnel; and (h) air traffic

controllers. 53 Fed.Reg. 47058 (App. I §III). Tests

must be performed for marijuana, cocaine, opiates, phen-

cyclidine (PCP) and amphetamines. Jd., § IV.

The regulations require testing of these employees on

a random basis. Jd., § V.C. To eliminate any supervisory

discretion in selecting the employees to be tested and to

avoid “potential bias toward and selective harassment

of an employee,” 53 Fed.Reg. at 8375, selection of em-

ployees to be tested must be made “using a random num-

ber table or a computer-based number generator that is

matched with an employee’s social security number, pay-

1 See 14 C.F.R. §§ 121.1, 135.1.

2 Air traffic control facilities operated by, or under contract with,

the FAA or te military are excepted. 53 Fed.Reg. 47057 App. I.

For the mos? pert, controllers at these facilities are covered by other

i drug testing programs.

| aati

6a

roll identification number, or any other alternative

method approved by the FAA.” 53 Fed.Reg. 47058,

§ V.C. After the first year of testing, employers must

conduct random tests at an annualized rate of not less

than 50 percent of the employees performing the func-

tions listed. Id., § V.C.(c) (2).°

The procedures under which the testing is to be done

are described in Procedures for Transportation Work-

place Drug Testing Program, 53 Fed.Reg. 47002 (Nov.

21, 1988) ; see also 53 Fed.Reg. 47056-61, and closely fol-

low the HHS drug-testing procedures for government

employees set forth at 53 Fed.Reg. 11,970 (April 11,

1988). Upon arriving at the “collection site,” the em-

ployee must present photographic identification or be

identified by a representative of the employer, and must

remove any outer garments, such as a coat or jacket.

The employee may choose to provide the required urine

specimen in a stall or otherwise partitioned area. The

toilet water is to be tinted with a blue dye to prevent

use of that water to adulterate the specimen, and a

monitor of the same gender as the employee must re-

main in the area, but gutside the stall. After receiv-

ing the specimen, the monitor must inspect it to ensure

that it is of proper volume, temperature, and color. The

monitor must then arrange, following specified chain-of- :

custody procedures, to ship the specimen to an HHS-

certified drug testing laboratory.

3 The regulations also require pre-employment testing, periodic

testing at the employee’s first medical examination for those em-

ployees required to take a Part 67 medical examination, post-accident

'testing, testing based on reasonable cause, and testing after return

to duty following a positive test or a refusal to test (return to

duty is authorized if the employee has completed drug rehabilitation,

and the medical review officer approves his return to work). 53

Fed.Reg. 47043-44, 47058, App. I § V. Petitioners do not challenge

these tests.

7a

The laboratory to which the specimen is sent must

perform an immunoassay test. If the specimen tests

positive, the test must be confirmed using gas chroma-

tography/mass spectrometry techniques. If the initial

positive test is confirmed, the employer’s Medical Re-

view Officer (who must be a qualified physician) de-

termines whether there is an “alternative medical ex-

planation” and in that connection must provide the em-

ployee with an opportunity to discuss the result and

submit any medical records regarding legally prescribed

medication. The employee may also demand a retest of

the original specimen at the original laboratory or an-

other HHS-certified laboratory.* In addition, there is an

absolute prohibition against the release of drug test re-

sults to third parties without the specific, written con-

sent of the employee.

Employees who test positive for prohibited drugs and

are unable to offer a satisfactory alternative explanation

must be removed from their positions, and may not re-

turn to duty except upon the recommendation of a Medi-

cal Review Officer or the Federal Air Surgeon.

B. This Litigation

Petitioners in this case include employees engaged in

various occupations within the commercial aviation in-

dustry who are subject to the FAA drug-testing rules,

the principal labor organizations in the industry, and an

organization of aviation employees and employers. Fol-

lowing the FAA’s issuance of the rules, timely petitions

for review were filed in this Circuit, the Fifth Circuit,

and the D.C. Circuit. Those petitions were then consoli-

dated in this proceeding. We have jurisdiction under 49

U.S.C.App. § 1486.

* The employee’s right to demand a retest is not part of the HHS

Guidelines for government agencies; it was added by DOT. 53

Fed.Reg. 47059, § VI.C.

8a

II. ANALYSIS

A. The Fourth Amendment Challenge

Petitioners’ primary contention is that the drug tests

required by the FAA are unreasonable searches in vio-

lation of the Fourth Amendment. Our disposition of this

issue is guided by the Supreme Court’s decisions in Na-

tional Treasury Employees Union v. Von Raab, ——

US. , 109 S.Ct. 1384, 103 L.Ed.2d 685 (1989), and

Skinner v. Railway Labor Executives Ass’n, —— US.

——, 109 S.Ct. 1402, 103 L.Ed.2d 639 (1989). In Von

Raab, the Court upheld a United States Customs Service

requirement that employees seeking transfers or promo-

tions to certain positions undergo urinalysis. In Skinner,

the Court upheld a Federal Railroad Administration pro-

gram requiring railroads to administer blood and urine

tests to train workers involved in major railroad acc:

dents, and permitting railroads to administer breath and

urine tests to employees who violate certain safety rules.

Von Raab and Skinner settle some of the threshold

questions in this case. First, drug testing performed by

private employers under compulsion of government regu-

lations constitutes governmental action subject to con-

stitutional restrictions. See Skinner, 109 S.Ct. at 1411-

12. Second, because “it is clear that the collection and

testing of urine intrudes upon expectations of privacy

that society has long recognized as reasonable,” urin-

alysis “must be deemed [a] search [] under the Fourth

Amendment.” Skinner, 109 S.Ct. at 1413; accord Von

Raab, 109 S.Ct. at 1390. Third, the usual Fourth

Amendment requirements of a warrant and probable

cause do not necessarily apply in the drug testing con-

text. Rather, when a search “serves special governmental

needs, beyond the normal need for law enforcement, it is

necessary to balance the individual’s privacy expectations

against the Government’s interests to determine whether

it is impractical to require a warrant or some level of

9a

individualized suspicion in the particular context.” Von

Raab, 109 §.Ct. at 1390.

In the present case it is clear that the FAA drug

testing requirements serve “special needs, beyond the

normal need for law enforcement” within the meaning

of Von Raab. As in Von Raab, the FAA rules specify

that “[t]est results may not be used in a criminal pros-

ecution of the employee without the employee’s consent.”

Id. Moreover, just as the Customs Service testing pro-

gram in Von Raab was designed “to deter drug use

among those eligible for promotion to sensitive positions

... and to prevent the promotion of drug users to those

positions,” id., so is the FAA’s program designed to de-

ter drug use among employees in safety-sensitive posi-

tions and to prevent the performance of safety-sensitive

functions by employees under the influence of narcotics.

We must therefore determine the constitutionality of the

FAA program by balancing the government’s interests

against the employees’ privacy interests.

In striking this balance, we take our primary guid-

ance from Von Raab, because we think that the random

testing at issue in this case is more closely analogous to

the facts of Von Raab than to those of Skinner. In Von

Raab, as in this case, the testing program did not re-

quire any level of individualized suspicion or the oc-

currence of any suspicion-triggering event; in Skinner,

on the other hand, testing was limited to those employees

involved in a train accident or safety rule violation. Ac-

cordingly, we proceed to consider whether this case can

be distinguished from Von Raab in a way that would

tip the balance against the constitutionality of the FAA’s

drug testing program.

In Von Raab, the Customs Service initiated a program

of testing employees for drugs as a condition of em-

ployment in positions that met any one of three criteria:

(1) direct involvement in drug interdiction or enforce-

10a

ment of related laws; (2) a requirement and the in-

cumbent carry a firearm; or (3) a requirement that the

incumbent handle “classified” material. See id. at 1388.

The drug tests followed procedures quite similar to the

FAA procedures at issue in this case. See id. at 1388-

89, 1394 n. 2. A union of federal employees challenged

the program as violative of the Fourth Amendment. The

Supreme Court upheld the testing program as applied to

the first two categories of employees listed above, and

remanded as to the third category (employees handling

classified information).

After concluding that the testing program invaded

reasonable expectations of privacy and that the tests were

motivated by special needs other than law enforcement,

the Court balanced the private and governmental inter-

ests at stake, and decided that the balance justified the

testing program. The Court reasoned that

[t]he Goverment’s compelling interests in prevent-

ing the promotion of drug users to positions where

they might endanger the integrity of the Nation’s

borders or the life of the citizenry outweigh the pri-

vacy interests of those who seek promotion to these

positions, who enjoy a diminished expectation of pri-

vacy by virtue of the special, and obvious, physical

and ethical demands of those positions.

Id. at 1897-98.

In reaching this conclusion, the Court rejected the pe-

titioners’ contention that there was insufficient evidence

of a drug problem in the Customs Service to justify sus-

picionless testing. The Court noted that drug abuse is

a pervasive social problem, and stressed that the testing

5 The Court found the record insufficiently clear to assess the

extent of the government’s interest in testing employees who hand!e

classified material, and therefore remanded for the court of appeals

“to clarify the scope of this category of employees subject to test-

ing.” Id. at 1397.

lla

program was aimed as much at deterrence as at detec-

tion. “In light of the extraordinary safety and national

security hazards that would attend the promotion of

drug users to positions that require the carrying of

firearms or the interdiction of controlled substances,” the

Court wrote, “the Service’s policy of deterring drug

users from seeking such promotions cannot be deemed

unreasonable.” Jd. at 1395.

The government interest in preventing drug use by

persons holding safety-sensitive positions in the aviation

industry is at least as compelling as the interest in pre-

venting drug use by Customs officers. Indeed, petitioners

concede that “the government has a strong interest in

assuring aviation safety and that the drug-related job-

impairment of any safety-sensitive aviation employee is

a basis for the most serious concern.” Reply Brief of

Petitioners at 15-16. Nonetheless, petitioners argue that

the FAA has failed to demonstrate a sufficiently high

level of drug use in the industry to justify its testing

program.

In our view, the evidence relied upon by the FAA is

stronger than the evidence relied upon by the Customs

Service in Von Raab. In Von Raab, the Service’s testing

scheme was not implemented in response to any perceived

drug problem among Service employees, and there was

evidence that only 5 employees of 3,600 tested positive

for drugs. Id. at 1394. As discussed earlier, the Su-

preme Court rejected the argument that this evidence

was insufficient to establish a substantial governmental

need, because of the deterrent purposes of the program

and the potential for serious harm. Id. at 1395.

In the present case, the FAA administrative record

included evidence that a number of pilots and other air-

line crew members had received treatment for cocaine

overdoses or addiction; that tests by companies in the in-

dustry had turned up instances of drug abuse by pilots

|

12a

and mechanics; and that drugs were present in the bod-

ies of pilots in two airplane crashes. Moreover, the

harm that can be caused by an airplane crash is surely

no less than the harm that might be caused by drug

impairment in the course of Customs Service employ-

ment. When viewed in this light, the need for the FAA’s

testing program equals, if not exceeds, that for the Cus-

toms Service program approved in Von Raab.

Petitioners also argue that the FAA testing program

intrudes more deeply on privacy interests than the pro-

gram approved in Von Raab.’ They point to the fact

that the FAA provides for unannounced (i.e., immediate)

testing, while the Customs Service program requires at

least five days’ notice; and that the FAA program is

random, while the Customs Service program is only ac-

tivated by certain events (ie. applying for certain

positions).

Although these factors add some weight to the “in-

vasion of privacy” side of the Fourth Amendment bal-

ance, they are insufficient to tip the scales against the

FAA drug testing program at issue here. The reason-

ing of the D.C. Circuit in Harmon v. Thornburgh, 878

F.2d 484 (D.C.Cir.1989), is instructive. In Harmon,

the court upheld (as to some employees) a Justice De-

partment testing plan that provided for random testing

and notice “on the same day, preferably within two

6 Although the FAA has made a showing of drug use by airline

employees, we note that nothing in Von Raab requires such a show-

ing. See Harmon v. Thornburgh, 878 F.2d 484, 487 (D.C.Cir.

1989) (“Nor is it necessary [under Von Raab] that a documented

drug problem exist within the particular workplace at issue.’’).

7 The petitioners have not urged that their expectation of privacy

is any less “diminished” than that of the Customs employees in Von

Raab. We therefore assume for the purposes of our decision that

this case is not distinguishable from Von Raab in that respect.

13a

hours, of the scheduled testing.” 878 F.2d at 486 (in-

terior quotation omitted). The court noted:

Certainly the random nature of the OBD testing

plan is a relevant consideration; and, in a particu-

lar close case, it is possible that this factor would

tip the scales. We do not believe, however, that this

aspect of the program requires us to undertake a

fundamentally different analysis from that pursued

by the Supreme Court in Von Raab.

Id. at 489. This is particularly true in light of the

FAA’s reasonable conclusion that random testing with-

out advance notice will prove to be a greater deterrent

than testing with advance notice.®

Finally, petitioners argue that the FAA plan grants

employers too much discretion. This argument is un-

persuasive. First, the strict randomness requirements

ensure that no employer will have discretion in deciding

which employees should be searched. Second, employers’

discretion as to how to structure their testing programs

will be limited by collective bargaining and the require-

ment that the FAA approve the plans of individual em-

ployers.®

In sum, we conclude that the Fourth Amendment is-

sue in this case cannot be meaningfully distinguished

from the Fourth Amendment issue addressed by the Su-

preme Court in Von Raab. We therefore reject petition-

ers’ constitutional challenge to the FAA drug testing

program.

8 For other decisions upholding random drug testing in the wake

of Von Raab, see American Fed. of Gov’t Employees v. Skinner, 885

F.2d 884 (D.C. Cir. 1989); National Fed. of Federal Employees

v. Cheney, 884 F.2d 603 (D.C. Cir. 1989); Thomson v. Marsh, 884

F.2d 113 (4th Cir. 1989).

® The FAA has stated that it will review the individual employer

programs to ensure that discretion is in fact sufficiently limited

under each plan. See 53 Fed. Reg. 47028.

l4a

B. The APA Challenge

Petitioners argue that the FAA failed to offer a satis-

factory explanation for its decision, and that the de-

cision was therefore arbitrary and capricious in viola-

tion of the Administrative Procedure Act, 5 U.S.C.

§ 706(2) (A). See Motor Vehicle Mfrs. Ass’n v. State

Farm Mutual Ins. Co., 463 U.S. 29, 43, 103 S.Ct. 2856,

2866, 77 L.Ed.2d 448 (1983) (agency must articulate

a satisfactory explanation for its action). In particular,

petitioners question the FAA’s decision to reject the rec-

ommendation of the National Transportation Safety

Board that the FAA rely on non-random forms of drug

testing.

This argument is without merit. The FAA, contrary

to petitioners’ contention, explained specifically why it

chose to require random testing, reasoning that there

was more evidence supporting the efficacy of random

testing programs than of non-random programs. See 53

Fed.Reg. 47034, 47035, 47048. Its decision that safety

concerns outweighed privacy concerns in this context was

a reasonable, if controversial, decision, and cannot be

overturned as arbitrary and capricious.

Petitioners also argue that the FAA’s decision to in-

clude flight attendants within the testing requirements

is inconsistent with prior FAA decisions denying peti-

tions of flight attendants to establish safety rules limit-

ing their on-duty time. The duty time decisions, how-

ever, do not stand for the proposition that impairment

of flight attendants’ performance is never a public safety

consideration. Rather, the FAA concluded that, on the

evidence before it, there was no correlation between flight

attendant duty time and risk to passengers. We see no

conflict between the duty time decisions and the inclu-

sions of flight attendants in the drug testing program.”

10 Although petitioners do not directly contend in this proceeding

that flight attendant positions are not safety-sensitive, it is none-

ee ee oe eet

15a

Accordingly, we hold that the FAA acted within its au-

thority in requiring random drug testing of flight at-

tendants.

III. CONCLUSION

For the foregoing reasons, we affirm the decision of

the Federal Aviation Administration.

theless worth noting that the administrative record adequately sup-

ports the FAA determination that such positions are, in fact,

safety-sensitive. Flight attendants must perform important safety

functions in the event of emergencies, and are also routinely re-

sponsible for ensuring that luggage is safely stored and the air-

plane doors properly closed and locked prior to departure.

16a

APPENDIX B

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Parts 61, 63, 65, 121, and 135

[Docket No. 25148; Amdt. Nos. 61-81, 63-25,

65-32, 121-201 and 135-28]

RIN 2120-AC33

Anti-Drug Program for Personnel Engaged in

Specified Aviation Activities

AGENCY: Federal Aviation Administration (FAA),

DOT.

ACTION: Final rule.

SUMMARY: This final rule sets forth regulations to re-

quire domestic and supplemental air carriers, commercial

operators of large aircraft, air taxi and commuter oper-

ators, certain commercial operators, certain contractors

to these operators, and air traffic control facilities not op-

erated by the FAA or the U.S. military to have an anti-

drug program for employees who perform sensitive safety-

or security-related functions. A special provision has been

added to the rule that provides that the final rule does

not apply to any person where compliance with the final

rule would violate the domestic law or policy of another

country. Testing under the rule will be conducted by an

employer prior to employment, periodically, randomly,

after an accident, based on reasonable cause, and after

an employee returns to duty to perform a sensitive safety-

or security-related function for an employer. The final

rule also will require that an employer provide EAP edu-

cation and training services to employees and supervisors.

17a

The rule is necessary to prohibit an employee from, per-

forming a sensitive safety- or security-related function

for an employer while that employee has a prohibited drug

in his or her system or if that employee has used drugs

as evidenced by a drug test showing the presence of drugs

or drug metabolites. The rule is intended to ensure a

drug-free aviation workforce and to eliminate drug use

and abuse in commercial aviation.

EFFECTIVE DATE: This final rule is effective on De-

cember 21, 1988.

FOR FURTHER INFORMATION CONTACT: Dr.

Robert S. Bartanowicz, Acting Deputy Director, Office of

Rulemaking (ARM-1), Federal Aviation Administration,

800 Independence Avenue SW., Washington, DC 20591;

telephone (202) 267-9679.

SUPPLEMENTARY INFORMATION:

Availability of Final Rule

Any person may obtain a copy of this final rule by

submitting a request to the Federal Aviation Administra-

tion, Office of Public Affairs, Attn: Public Inquiry Center

(APA-230), 800 Independence Avenue SW., Washington,

DC 20591, or by calling (202) 267-3484. Requests must

include the amendment number identified in this final

rule. Persons interested in being placed on a mailing

list for future rulemaking actions should request a copy

of Advisory Circular 11-2A, Notice of Proposed Rulemak-

ing Distribution System, which describes the application

procedure.

Background

On December 4, 1986, the Federal Aviation Adminis-

tration (FAA) issued an advance notice of proposed rule-

making (ANPRM) (51 FR 44432; December 9, 1986)

entitled “Control of Drug and Alcohol Use for Personnel

Engaged in Commercial and General Aviation Activities.”

18a

The ANPRM invited comment from the public on drug

and alcohol abuse by personnel in the aviation industry

and the options available to the FAA for regulatory or

other action in the interest of aviation safety. The FAA

received over 650 written comments in response to the

issues raised in the ANPRM.

On March 3, 1988, the FAA issued a notice of proposed

rulemaking (NPRM) (53 FR 8368; March 14, 1988) en-

titled ‘‘Anti-Drug Program for Personnel Engaged in Spe-

cified Aviation Activities.” The NPRM set forth an anal-

ysis of the comments received on the ANPRM and pro-

posed regulations for public comment. The FAA received

over 260 written comments on the proposals contained in

the NPRM.

The FAA also held a series of public hearings on the

regulations proposed in the NPRM. These hearings were

held on June 2, 1988, in Washington, DC; June 7, 1988,

in Denver, Colorado; and June 9, 1988, in San Francisco,

California. Each of the hearings was recorded by a court

reporter. The transcript of each hearing and any state-

ments or other material, submitted to the hearing panel

during the hearings, have been placed in the public docket.

This material also has been reviewed in the development

of the final rule.

Current Rules. The FAA’s comprehensive anti-drug pro-

gram is one action in a long history of actions to combat the

use of drugs and alcohol in the aviation industry. The focus

of the majority of these actions has been on commercial avi-

ation personnel, particularly the cockpit and cabin crew.

For example, pilots, flight attendants, flight engineers, and

flight navigators may not act as a crewmember of a civil

aircraft within eight hours after drinking an alcoholic

beverage; while under the influence of alcohol; with 0.04

percent, or more, alcohol in their blood; or while using

any drug that affects their faculties in any way contrary

eta to hl areal

OE Nn ns AL ects Heee so

tend

hela sr Nabe 0 ae at os

a RA tt CeO ie Nad Dt Bhs ares Stet SIE ERE iin CA wept

19a

to safety. Also, crewmembers may be tested in the con-

text of receiving medical care immediately after an acci-

dent. When there is a reasonable basis to suspect that

one of these individuals has violated any of the above

restrictions, these crewmembers must furnish, to the FAA,

the results of any test taken within four hours of acting,

or attempting to act, as a crewmember that indicates the

presence of alcohol or any such drug in the person’s sys-

tem. Moreover, pilots, flight attendants, flight engineers,

and flight navigators are required to submit to a test to

indicate the percentage of alcohol in the blood when re-

quested by a law enforcement officer who suspects that a

crewmember may have violated a State or local law gov-

erning the operation of an aircraft while under the in-

fluence, or impaired by, drugs or alcohol.

The FAA may deny an application for a certificate or

rating for up to one year, or may suspend or revoke an

existing certificate or rating, in the case of any pilot,

flight engineer, or flight navigator who has been convicted

of violaiing a Federal or State law relating to drug traf-

ficking or possession; who has violated the proscriptions

described above; who has refused to furnish the results of

any test that would indicate the presence of alcohol or

drugs taken within four hours of acting, or attempting to

act, as a crewmember; or who has refused to submit to

an alcohol test requested by a law enforcement officer in-

vestigating violations of State or local laws. The FAA

also may deny an application for a certificate or rating

for up to one year, or may suspend or revoke an existing

certificate or rating, in the case of any air traffic control

tower operator, aircraft dispatcher, mechanic, repairman,

or parachute rigger who has been convicted of a violation

of a Federal or State law relating to drug trafficking or

possession.

The Aviation Drug-Trafficking Control Act of 1984,

which added language to sections 602 and 609 of the Fed-

eral Aviation Act of 1958, mandates that the FAA take

20a

certain actions regarding airmen involved in drug traffick-

ing activities. The Administrator is required to revoke

the airman certificate of any airman who has been con-

victed of violating any Federal or State law relating to a

controlled substance, other than simple possession, if an

aircraft was used in, or was used to facilitate, the com-

mission of the offense and the person served as an airman,

or was onboard the aircraft, in connection with the com-

mission of the offense. The Administrator has no discre-

tion to review the conviction for the substantive offense.

Under the 1984 legislation, the Administrator was pro-

hibited from reissuing a certificate to that airman for

up to five years but could reissue a certificate after an

absolute minimum of one year, in certain extremely lim-

ited circumstances, if revocation was excessive and con-

trary to the public interest. As part of the Federal Avia-

tion Administration Drug Enforcement Assistance Act of

1988, Congress amended sections 602 and 609 of the FAA

Act, among other amendments to the Act, in October 1988.

The statutory language now provides that the Adminis-

trator shall not issue an airman certificate to any person

whose certificate has been revoked for aviation drug

trafficking activities unless the airman is acquitted of

the offense, a conviction upon which revocation is based

is reversed on appeal, or the Administrator determines

that issuance of an airman certificate will facilitate law

enforcement efforts after a request from a Federal or

State law enforcement official. The final rule requiring a

comprehensive anti-drug program for employees in com-

mercial aviation is consistent with these previous actions

taken by the FAA.

The FAA’s commitment to a drug-free workforce also

applies to its own employees. The Department of Trans-

portation began random drug testing of DOT employees

in safety- and security-sensitive functions in September

1987. The Secretary’s goal is to establish and maintain

a drug-free workplace as intended by Executive Order

12564 and as directed by Presidential memorandum dated

aaa ieadeninaaeinemmmeiaieeeieel

2la

October 4, 1986. It is the opinion of the Department of

Transportation that random drug testing is the most

effective means of determining the presence of drugs or

drug metabolites that may adversely affect an employee’s

performance of safety- or security-sensitive job functions.

Pursuant to the Department’s program, an employee of

the Department will be removed from Federal service un-

der several circumstances: refusal to enter or to suc-

cessfully complete a drug rehabilitation or abatement pro-

gram; repeat usage of drugs; refusal to provide a urine

specimen for drug testing; adulteration or substitution

of a urine specimen; on-duty use of illegal drugs; or

a determination that a DOT employee has engaged in

illegal drug trafficking.

In order to ensure that aviation safety is not compro-

mised by a failure to detect drug users in the aviation

industry, the FAA believes that it is appropriate and

necessary to establish a comprehensive anti-drug program

at this time.

Existing Industry Programs. As part of their com-

ments to the ANPRM and the NPRM, many employers

note that they have implemented drug testing programs

or employee rehabilitation programs. For example, al-

though their drug testing programs were not specifically

described, Martin Aviation implemented a drug testing

program in February 1987 and Suburban Airlines has re-

quired preemployment drug testing of flight crew appli-

cants for over a year. Federal Express Corporation cur-

rently conducts preemployment testing of all applicants

and “reasonable suspicion testing” of all employees.

Tramco, Ine. is a certificated repair station employing

over 600 individuals and repairing over 100 aircraft per

year. Tramco instituted a drug testing and counseling

program “several years ago” and believes that the pro-

gram yields substantial benefits to both employees and

employers. Tramco tests all applicants for jobs and con-

ducts tests based on probable cause. Tramco’s tests based

22a

on probable cause are triggered by reports of employee

drug use, employee attendance patterns that may suggest

a drug problem, accidents, and observation by super-

visors. A Tramco employee who tests positive for drugs

is suspended for a minimum of one week and may not

return to work until a drug test shows no evidence of

drug use. Tramco estimates that, consistent with general

statistics, 20 percent of its workforce has had some in-

volvement with controlled substances. As of the time of

its comment to the NPRM, Tramco identified 10 percent

of its employees as individuals who had used drugs.

Rocky Mountain Helicopters, Inc. implemented a drug

testing program for its employees in July 1986. Rocky

Mountain Helicopters tests all pilots, mechanics man-

agers, and others who can affect aviation safety using

preemployment, random, probable cause, and postaccident

testing. Rocky Mountain Helicopters does not pay an em-

ployee’s rehabilitation costs but will consider rehiring any

employee who completes an approved rehabilitation pro-

gram. Petroleum Helicopters, Inc. began a preemploy-

ment and periodic testing program in 1982 and supports

mandatory drug testing. Petroleum Helicopters denies

employment to any applicant, and discharges any em-

ployee, who tests positive in a drug test. Petroleum Heli-

copters does not concur with the proposal to provide a

rehabilitation opportunity to employees on the basis that

an employer should not accept the risk of repeated illegal

drug use among maintenance or flight personnel. -

The FAA believes that the comprehensive anti-drug

program, promulgated by this final rule, is not a novel

concept. In light of the FAA’s long history of regulatory

action in the area of drug use in aviation and the sig-

nificant number of industry drug testing programs cur-

rently implemented by aviation employers, the FAA be-

lieves that the agency is justified in requiring the com-

mercial aviation industry to implement similar compre-

hensive anti-drug programs.

23a

Discussion of Comments

General Overview of the Major Issues

The FAA received 261 comments in response to the

NPRM. The FAA considered all timely-filed comments

submitted in response to the NPRM and the testimony

of 20 individuals who presented statements at the three

public hearings held by the FAA. During the public

hearings, the Secretary of Transportation, James H.

Burnley, requested information from several individuals

who presented statements at the hearings. The comment

period for the NPRM closed on June 13, 1988. In order

to accommodate the individuals who submitted supple-

mental information pursuant to the Secretary’s request,

the FAA also considered comments that were submitted

as late as July 1, 1988.

There were several major themes presented by the

commenters. Many commenters focus on the lack of evi-

dence of significant drug use or drug abuse in the avia-

tion industry. The commenters particularly stress this

point with respect to the cockpit crew based on age, in-

come, managerial supervision, close working relationships

with peers, periodic medical exams to determine fitness

for duty, and professionalism of the crew. Based on the

lack of evidence, these commenters conclude that estab-

lishment of a drug testing program is unwarranted and

unconstitutional. Regardless of the amount of evidence,

the majority of commenters agree with the FAA’s assess-

ment that drug use and substance abuse have no place in

the aviation environment. Some commenters note that

the FAA’s anti-drug stance is commendable, but the true

issue is the type of program that evolves from that

stance. Many commenters support the FAA’s efforts to

develop a comprehensive anti-drug program that would

achieve a drug-free commercial aviat‘on workforce and

agree that a program to achieve a drug-free aviation

environment is beneficial.

24a

There is substantial, although not universal, support

for a drug testing program using state-of-the-art urine

testing. The gas chromotography/mass_ spectrometry

(GC/MS) method, approved by the Department of Health

and Human Services (DHHS), is recognized by the com-

menters as the most accurate method of analysis for the

presence of drugs or drug metabolites in urine if rigorous

collection and analysis procedures, such as those contained

in the DHHA mandatory guidelines, are followed. (As

discussed in detail elsewhere in this preamble, the Depart-

ment of Transportation is publishing “Procedures for

Transportation Workplace Drug Testing Programs”

which are adopted in this final rule in lieu of the DHHS

guidelines. These DOT-wide procedures closely resemble

the DHHS guidelines and are used-because the DHHS

guidelines are not drafted for application by entities

other than Federal agencies.) While some concerns were

raised about the testing procedures, these concerns gen-

erally involve drug testing programs and procedures in

the early 1980s that did not embody the critical safe-

guards of a properly-administered testing program.

Certain types of testing proposed in the NPRM receive

significant support by the commenters. These types of

testing include preemployment testing and postaccident

testing. Periodic testing and testing based on reasonable

cause received substantial support from the commenters.

Some support for testing based on reasonable cause is

predicated on traditional constitutional standards that

apply to a search of the person.

There is significant and strongly-held opposition to

random testing. However, the FAA’s drug testing pro-

gram, including random testing as a critical element, is

supported by some commenters. The objections to random

testing are based on legal or constitutional issues, pri-

vacy issues, privacy issues, and the invasive nature of

random testing based on personal grounds, cost issues,

and the absence of a demonstrated need for a compre-

25a

hensive testing program assuming a low level of drug use

in the industry.

Of those commenters who address the issue, there is

agreement that the complexity, cost, and operational im-

pact burdens of the rule would be significantly greater

on small entities in the aviation industry. Finally, the

commenters express significantly different opinions in the

area of employee assistance programs (EAP). The pri-

mary differences surround the issues of the circumstances

under which an employee is offered an opportunity for

rehabilitation and the entity or individual who is respon-

sible for payment of rehabilitation costs. Several major

air carriers have already addressed this issue through

insurance coverage or by labor-management agreement.

However, even some of these organizations, although sup-

portive of EAPs, oppose a broad, Federally-mandated

EAP requirement. Labor organizations clearly support

expansive EAP opportunities and services. Small entities

oppose EAP requirements on many grounds, including

cost and possible negative coworker attitudes exhibited

toward rehabilitated employees.

The commenters differ regarding the method of achiev-

ing a drug-free aviation workforce and the manner in

which the FAA would be involved in any program. The

primary differences arise regarding the type and scope

of testing used to identify sensitive safety- or security-

related personnel who use drugs and the choices offered

to those individuals who are identified as drug users.

Labor Unions and Organizations Representing Em-

ployees. In general, unions or organizations representing

employees in aviation oppose the comprehensive manda-

tory drug testing proposed in the NPRM. Labor unions

and employee organizations favor EAP and broad re-

habilitation rights for all employees. These organizations

oppose random drug testing but, with some qualifications,

these organizations see a role for preemployment testing,

26a -

postaccident testing, testing based on reasonable cause,

and testing during and after rehabilitation to monitor an

individual’s progress.

The International Association of Machinists and Aero-

space Workers (IAM) opposes any industry-wide drug

and alcohol testing until hard evidence of an industry

drug problem that jeopardizes aviation safety is substan-

tiated and documented. The Independent Union of Flight

Attendants (IUFA) opposes all forms of mandatory drug

testing of employees. The Independent Federation of

Flight Attendants (IFFA) objects generally to drug test-

ing as unwarranted governmental intervention into labor-

management relations but would support preemployment

screening and postaccident testing if reasonable cause for

such testing can be objectively illustrated. IFFA objects

specifically to random testing in any form as unconstitu-

tional and contrary to labor law. IFFA believes that the

focus of any drug testing program should be limited to

impairment on the job and states that no currently avail-

able testing procedure can determine drug impairment on

the job. The Asscciation of Flight Attendants (AFA)

believes that drug testing of flight attendants is not

warranted. However, AFA and the Association of Pro-

fessional Flight Attendants (APFA) support preemploy-

ment testing of applicants seeking jobs in the industry if

that testing is not used to discriminate against applicants

on the basis of disabilities unrelated to drug use. AFA

also would not oppose postaccident testing of pilots or

probable cause drug testing of employees who are under

the influence of drugs if these samples were collected by

an FAA inspector. APFA opposes random testing, post-

accident testing absent individualized suspicion, and test-

ing based on reasonable cause as proposed. The Flight

Engineers’ International Association (FEIA) opposes all

testing except in the case where probable cause exists to

believe that an employee is impaired by drugs; in order

to protect employees from harassment, FEIA states that

OE en eee

27a

any determination to test an employee based on probable

cause for impairment should be reviewed by a neutral

party. The Teamsters Union could support preemploy-

ment screening; testing based on reasonable suspicion to

believe that an employee’s actual or current impairment

has, or is, affecting job performance or workplace safety;

periodic testing to maintain medical certification; and

testing after an accident or a “near miss” if there is a

reasonable basis to suspect that human error may have

been a causal factor.

The Air Line Pilots Association (ALPA), representing

41,000 pilots employed by 44 large and small airlines, is

firmly opposed to all forms of drug and alcohol abuse by

airline personnel. ALPA primarily is opposed to random

and periodic testing based on their belief that these tests

are offensive, ineffectual, unjustified, and unconstitu-

tional. ALPA believes that if there is drug use among

commercial pilots, the incidence of drug use would be less

than 0.5 percent. On this basis, ALPA asserts that wide-

scale random testing of the relatively small aviation popu-

lation will result in a significant number of false-positive

test results. ALPA does not oppose testing prior to em-

ployment, testing after an accident, testing in circum-

stances where there are reasonable grounds to suspect

drug use, and testing to monitor rehabilitation.

ALPA believes that the approach to the drug abuse

problem articulated in the NPRM is inappropriate.

ALPA instead urges the FAA to consider an approach

similar to the Human Intervention Motivation Study

(HIMS) program developed to identify and treat alco-

holism among pilots. The key elements of the HIMS

program are education, peer involvement, intervention,

confrontation, and rehabilitation. Although the HIMS

program has focused on treatment of pilots who demon-

strate a problem with alcohol, ALPA sponsored a HIMS

drug abuse training program in November 1987 which

the FAA attended.

28a

Labor and employee organizations also strongly sup-

port limitations on an employer’s ability to exclude any

employee from an opportunity for rehabilitation and limi-

tations on an employer’s ability to discharge an em-

ployee. Most organizations, including IUFA, IFFA, AFA,

and APFA, strongly support regulations that would re-

quire an employer to establish and participate in compre-

hensive, nonpunitive EAP services established by collec-

tive bargaining or negotiation and available to all em-

ployees. ALPA agrees that any regulations should clearly

recognize that unions have collective bargaining rights

under Federal labor laws; ALPA suggests that any anti-

drug regulations promulgated by the FAA should ensure

that the regulatory requirements do not interfere or over-

ride the union’s collective bargaining rights. FEIA sup-

ports EAP services, mandatory for each carrier and paid

for by the carrier, for rehabilitation of all employees re-

gardless of the circumstances that precipitated a drug

test. IAM suggests that FAA regulations should be

guidelines, applicable only to carriers who have a docu-

mented substance abuse problem affecting aviation safety,

that stress education, prevention, rehabilitation, and pro-

tection of an employee’s privacy.

Employers and Organizations Representing Employers.

Most employers support mandatory drug testing of em-

ployees and limitations on an employees opportunity for

rehabilitation. Part 121 and Part 135 certificate holders

do not express the same opinions regarding the proposals

in the NPRM. The general views held by Part 121 cer-

tificate holders are characterized by the comments sub-

mitted by the Air Transport Association of America

(ATA). ATA supports the FAA’s comprehensive drug

testing program and favors an opportunity for rehabili-

tation only for those employees who volunteer for re-

habilitation. In the area of EAP services, Part 121 cer-

tificate holders generally favor flexibility and latitude for

an employer to design a company EAP. American Air-

- he Lee ee

29a

lines, however, favors industry-wide standard EAP re

quirements.

Most Part 135 certificate holders and small aviation

businesses object to the drug testing requirements pro-

posed in the NPRM. The Regional Airline Association

(RAA), which represents many Part 135 certificate hold-

ers, opposes random testing; RAA also suggests that the

random selection rate be set at a rate less than the maxi-

mum 125 percent rate proposed in the NPRM if the FAA

mandates a random testing requirement. The Primary

objection of Part 135 certificate holders and small busi-

nesses is to the proposed requirement to offer an oppor-

tunity for rehabilitation to an employee. These organiza-

tions oppose mandated rehabilitation because of the eco-

nomic burden that would be imposed on a small operator.

The National Air Transport Association (NATA) sug-

gests, in its June 2, 1988 testimony, that Part 135 cer-

tificate holders employing 100 or fewer covered employees

should be exempted from all requirements of the proposed

anti-drug program.

Grace Flying Service, Inc., a Part 135 certificate holder

conducting single-engine air taxi services, flight instruc-

tion, and aerial application services, opposes drug testing

of employees. Grace Flying Service strenuously objects

to any drug tests, whether scheduled or random, and

would be reluctant to test its employees even if testing is

mandated by the FAA.

The National Business Aircraft Association (NBAA)

concurs with the FAA’s anti-drug program with certain

reservations. NBAA primarily is concerned about the

constitutionality of random drug testing and the FAA’s

reliance on laboratory testing results that may be un-

reliable in detecting drugs or drug metabolites proposed

to be analyzed in the NPRM.

Individual Commenters. The FAA received 170 com-

ments from individuals. The majority of these individ-

30a

uals are pilots employed by major airlines and self-

employed pilots who would be subject to the requirements

of the proposed rule. The FAA also received comments

from general aviation pilots and individuals who are not

employed in the commercial aviation industry. The vast

majority of the individual commenters oppose the drug

testing requirements of the proposed rule based on con-

stitutional objections, failure of the FAA to demonstrate

a drug problem in the aviation community, and perceived

inaccuracies of drug testing collection and analysis. A

minority of individual commenters generally support the

FAA’s anti-drug proposals and primarily support the

testing requirements. These individuals are private citi-

zens or consumers who base their support on the need to

ensure that aviation personnel are drug free, particularly

on the job. The strongest individual support is expressed

by letters from the family and friends of a passenger

who was killed in the crash of Continental Air Express

Flight 2286 near Durango, Colorado. The comments from

the family and friends of the deceased passenger urge

the FAA to do everything within its statutory authority

to prevent a similar tragedy in the future.

Specific Issues

Discussion of the constitutional! issues regarding ran-

dom and periodic drug testing. A number of commenters

have questioned the constitutionality of drug testing pro-

grams for aviation personnel. Although the state of the

case law is still evolving in rapid fashion and no defini-

tive Supreme Court resolution of many relevant and com-

plex issues has been achieved, the FAA feels confident

that testing required under this rule will pass constitu-

tional scrutiny. The FAA recognizes that there are legit-

imate and significant constitutional concerns surrounding

drug testing in general and random drug testing as a

specific component of drug testing. The FAA acknowl-

edges the current widescale litigation and apparent dis-

parate judicial opinions on drug testing programs.

ee ee ‘ mits tem" ob

ey

Seat ce Rete a ate ie see ade

3la

FAA Response. The principles of the Fourth Amend-

ment to the U.S. Constitution are paramount in scrutiniz-

ing the fundamental legality of many drug testing pro-

grams. As a threshold legal matter, the Fourth Amend-

ment applies to “searches” conducted or mandated by the

government and protects individuals against “unreason-

able searches and seizures.” Action of a private party

does not constitute State (or Federal) action unless there

exists a close nexus between the state and the action

in question. Jackson v. Metropolitan Edison, 419 US.

345 (1974); Moose Lodge No. 107 v. Irvis, 407 U.S. 162

(1972).

Assuming that the drug testing programs called for

under the final rule do implicate the government, a second

issue then arises concerning whether urine tests under

these programs are “searches” within the meaning of the

Fourth Amendment. Although most courts to address the

issue to date have ruled that toxicological testing of em-

ployees for the purpose of determining fitness for duty

is a search within the meaning of the Fourth Amendment,

the issue is not entirely settled. See Wyman v. James,

400 U.S. 309, 317-338 (1971) (government welfare case-

worker’s “home visit” as a precondition for assistance

payments is not a Fourth Amendment search). See also,

Lovvorn v. City of Chattanooga, 846 F.2d 1539, 1553-

1554 (6th Cir. 1988) (Guy, J., dissenting), panel decision

vacated and rehearing en bane ordered, (August 3,

1988) ; National Treasury Employees Union v. von Raab,

808 F.2d 1057, 1060, 1062 (5th Cir. 1987) (Higgin-

botham, J., concurring). Cf. Mack v. United States,

F.B.I., 814 F.2d 120, 125 n.2 (2nd Cir. 1987).

Also assuming, arguendo, that urine tests of aviation

personnel for illegal drugs are “searches” within the

meaning of the Fourth Amendment, it is clear that while

searches ordinarily must be conducted pursuant to a war-

rant issued on probable cause grounds, such a require-

ment is not always necessary. Almeida-Sanchez v. United

32a

States, 4138 U.S. 266, 277 (1973) (Powell, J., concur-

ring). Where, for example, “* * * the burden of obtain-

ing a warrant is likely to frustrate the governmental

purpose behind the search * * *,” [Camera v. Municipal

Court, 387 U.S. 528, 583 (1967)], the Supreme Court

has routinely held that a warrant is not required by the

Fourth Amendment. See e.g., Griffin v. Wisconsin, 107

S.Ct. 3164, 3167 (1987); New Jersey v. T.L.O., 469 U.S.

325, 340 (1985). The Supreme Court has likewise found

that the probable cause standard is inappropriate where

it would defeat the purpose that the search is designed to

achieve. See e.g., New Jersey v. T.L.0., 469 U.S. at 340-

342; O'Connor v. Ortega, 107 S.Ct. 1492, 1501-1502

(1987) (plurality opinion) (upholding the search of a

public employee’s office for work-related noninvestigatory

reasons on less than probable cause grounds); United

States v. Martinez-Fuerte, 428 U.S. 548, 560-561 (1976)

(footnotes omitted) (while “* * * some quantum of indi-

vidualized suspicion is usually a prerequisite to constitu-

tional search or seizure,] * * * the Fourth Amendment

imposes no irreducible requirement of such suspicion’’).

Rather, “[t]he fundamental command of the Fourth

Amendment is that searches and seizures be reasonable

** *” New Jersey v. T.L.0., 469 U.S. at 340. In deter-

mining the reasonableness of a search, the Supreme Court

has repeatedly stressed the importance of the facts par-

ticular to the search while acknowledging that the test

of reasonableness “* * * is not capable of precise defini-

tion or mechanical application.” Bell v. Wolfish, 441 U.S.

520, 559 (1979). In analyzing a drug testing program,

«* * * what is reasonable depends on the context within

which a search takes place.” New Jersey v. T.L.O., 469

U.S. at 337.

In scrutinizing whether particular searches comport

with the Fourth Amendment, courts have adopted a bal-

ancing test. In general, to support a claim that a search

of an individual or the individual’s property is reason-

ae ee

te al ae nn er ee

wet.

to Dee me Ladi —

~ <ebtad ed se

:

9

33a

able, the government must demonstrate that, on balance,

the public’s legitimate interest on conducting the search

outweighs the individual’s legitimate expectation of pri-

vacy. See e.g., United States v. Montoya de Hernandez,

473 U.S. 531, 587 (1985); United States v. Villamonte-

Marquez, 462 U.S. 579, 588 (1983) ; Delaware v. Prouse,

440 U.S. 648, 654 (1979). Thus, the courts must “* * *

consider the scope of the particular intrusion, the manner

in which it is conducted, the justification for initiating

it, and the place in which it is conducted.” Bell v. Wol-

fish, 441 U.S. at 559.

Viewed in this light, it is beyond dispute that the public

has an overriding interest in assuring that sensitive

safety- and security-related aviation personnel perform

their duties free of illegal drugs. The drug problem in

society in general and evidence of drug use in the avia-

tion industry in particular are documented elsewhere in

the preamble of this final rule. The impairing effects of

illegal drugs and the substantial risks to public safety

posed by aviation employees who use illegal drugs under-

lies the compelling governmental interests in promulgat-

ing this final rule.

In contrast, the drug testing requirements of the final

rule involve a minimal invasion of privacy. As the Su-

preme Court has indicated, where searches are under-

taken in situations where individualized suspicion is lack-

ing, other safeguards must be relied upon to ensure that

the discretion of the party conducting the search is prop-

erly defined and the scope of the search is limited. See

Delaware v. Prouse, 440 U.S. at 654-655 (footnote

omitted); New York v. Burger, 107 S.Ct. 2686, 2648

(1987). The drug testing requirements of the final rule

place significant constraints on an employer’s discretion

in conducting drug testing. For example, the requirement

for random drug testing calls for selection of an employee

to be tested in a scientifically-acceptable manner, such as

use of a computer-based random number generator. Re-

34a

quirements for testing based on reasonable cause cr post-

accident testing also are severely circumscribed in order

to limit an employer’s discretion in administering such

tests to employees. Also, the FAA will review the actual

employer anti-drug programs, required to be submitted

to the agency in accordance with provisions of the final

rule, to ensure that discretion is in fact limited in the

administration drug tests under these programs. Cf.

National Treasury Employees Union v. Reagan, No. 86-

4058, slip op. at 14 (E.D.La. April 29, 1988) (holding

that the constitutionality of Executive Order requiring

Federal agencies to establish drug testing programs for

Federal employees was not ripe for review since each

agency had not implemented a finalized, particular plan).

The actual testing procedures that each employer is

required to implement under this final rule also are

tailored narrowly to respect an employee’s reasonable

expectation of privacy. The DOT procedures governing

collection of urine samples, which are based on the

DHHS guidelines, are carefully designed to preserve pri-

vacy while protecting the integrity of the sample. The

final rule contains a number of important employee safe-

guards, including privacy during collection under the

majority of circumstances, stringent laboratory safe-

guards, and provisions for challenging results. Other

employee drug testing programs incorporating the collec-

tion and testing procedures of the DHHS guidelines have

been upheld against constitutional attack. The DOT pro-

cedures so closely resemble the HHS guidelines in all

pertinent respects that the Department of Transporta-

tion is confident that these procedures also will be upheld.

See American Federation of Government Employees v.

Dole, 670 F.Supp. 45 (D.D.C. 1987), appeai docketed,

No. 87-5417 (D.C.Cir. Dec. 11, 1987) (upholding the

constitutionality of the Department of Transportation

program for random drug testing of safety- and security-

sensitive agency employees) ; National Association of Air

Traffic Specialists v. Dole, 2 Ind.Emp.Rts. Cases (BNA)

eh eS A

<< mI

ile Petite cial Se EE AN ORI Chee Brvenecttlnn bial Ws

35a

68 (D.Alaska 1987) (denying a motion for a preliminary

injunction against the FAA use of urinalysis drug test-

drug testing as part of an annual physical examination

of the agency’s air traffic specialists) .

Equally significant is the fact that urine drug testing

of sensitive safety- and security-related employees is to

be conducted in the “context” of the employment rela-

tionship. As the Supreme Court has pointed out, “[t]he

operational realities of the workplace * * * may make

some employees’ expectation of privacy unreasonable.”

O’Connor v. Ortega, 107 S.Ct. at 1498. This is particu-

larly important in circumstances where the employee

works in an industry in which his or her activities are

subject to extensive regulation. Thus, persons who work

in such “closely regulated” industries have a “reduced

expectation of privacy” [New York v. Burger, 107 S.Ct.

at 2646] and, “in effect consent[] to the restrictions

placed upon them” [Almeida-Sanchez v. United States,

413 U.S. at 271]. For these very reasons, two Federal

courts of appeals have upheld urinalysis testing, in the

absence of particularized suspicion, in industries where

pervasive regulation of privacy. See Rushton v. Nebraska

Public Power Dist., 844 F.2d 562, 566 (8th Cir. 1988)

(nuclear plant operators); Shoemaker v. Handel, 795

F.2d 1136, 1142 (8rd Cir.), cert. denied, 479 U.S. 986

(1986) (jockeys); Policemen’s Benevolent Ass’n., Local

818 v. Township of Washington, 850 F.2d 133 (8rd Cir.

1988) (police officers).

It is beyond dispute that aviation has always been

subject to pervasive regulation by the government and

by employers themselves. As one Federal district court

has noted:

[t]he rationale of the Third Circuit upholding

drug urinalysis for jockeys in order to protect the

integrity of horse racing is even more compelling

when the public need for air safety is considered.

If horse racing is recognized as a closely or perva- .

36a

sively regulated activity, then aviation activities and

the aviation industry are as much or possibly more

closely regulated.

Indeed, the creation of a federal agency charged

with the responsibility for ensuring safe air travel

reflects the public interest in air safety. * * * [T]he

public perception of air safety not only is critical to

the airline industry but to all who fly. * * * [C]lose

and pervasive regulation of aviation related activi-

ties is well established and * * * air safety relates to

serious risk or hazards which require close and con-

stant attention. National Association of Air Traffic

Control Specialists v. Dole, 2 Ind. Emp. Rts. Cases

(BNA) at 78.

The FAA recognizes that a number of Federal and

State courts have rejected government-mandated drug

testing program of Fourth Amendment grounds. How-

ever, even courts striking drug testing programs have

recognized that drug testing is appropriate in other con-

texts. See e.g., Lovvorn v. City of Chattanooga, 846 F.2d

at 1553-1554 (Martin, J.) (“When determining then,

whether a mandatory drug search is ‘reasonable,’ we be-

lieve that, as the costs to society of an impaired em-

ployee increase, the requisite level of suspicion that a

drug problem exists decreases.”) ; Policemen’s Benevolent

Ass’n, Local 318 v. Township of Washington, 672 F.Supp.

779, 792 (D.N.J. 1987), rev’d, 850 F.2d 133 (8rd Cir.

1988) (“[T]he need to prevent a major airline disaster

presents a far more compelling rationale than those pre-

sented by the municipality in support of testing its po-

lice officers.”’) ; American Federation of Government Em-

ployees v. Meese, No. C-88-1419-SAW (N.D.Cal. June 16,

1988) (issuing a preliminary injunction against a Bu-

reau of Prison plan to test randomly all agency em-

ployees but nonetheless noting that “[t]here are cases in

which compulsory drug testing may be justified in the

interest of public safety or security.” Memorandum opin-

ion at 2).

“=, oe eS oe

SN ea eS See SS

37a

The FAA also is aware of the recent Ninth Circuit

decision holding unconstitutional regulations promulgated

by the Federal Railroad Administration—mandating

blood and urine tests of railroad employees who are in-

volved in certain train accidents and fatal incidents and

authorizing breath and urine tests after certain acci-

dents, incidents, and rule violations—because the rules_

do not require a showing of “particularized suspicion”

drug or alcohol impairment prior to testing. Railway

Labor Executives’ Association v. Burnley, 839 F.2d 575

(9th Cir.), cert. granted, 108 8.Ct. 2033 (1988). The

Ninth Circuit based its views, in part, on the proposition

that “* * * the vast bulk of [railroad] safety regulation

is directed at owners and managers of railroads, not em-

ployees.” Id. at 585. The U.S. government disagrees with

the Ninth Circuit panel’s decision, which is contrary to

rulings in other Federal appellate courts. Moreover, con-

trary to the Ninth Circuit’s views of the Federal Rail-

road Administration’s jurisdiction over railroad employ-

ees, FAA’s jurisdiction over employees in the aviation

industry is clear and should not be _— to challenge

on this basis.

The Supreme Court has granted the government’s pe-

tition for a writ of certiorari in Railroad Labor Execu-

tives’ Association v. Burnley and has ordered that this

case be argued this term “in tandem” with National

Treasury Employees Union v. von Raab, 816 F.2d 170

(5th Cir. 1987), cert. granted, 108 S.Ct. 1072 (1988) -

(upholding drug testing of applicants for critical safety

or security sensitive positions in the U.S. Customs Serv-

ice). Decisions in these cases may not be forthcoming

until the spring of 1989. However, in the absence of

Supreme Court guidance, the FAA remains convinced

that the need for drug testing by urinalysis in the avia-

tion industry to determine fitness for duty of sensitive

safety-or security-related employees and, thereby, to en-

sure public safety clearly outweighs the privacy inter-

est of individuals in this class.

38a

While not totally free from doubt, it is the opinion

of the Department of Transportation that the FAA’s

anti-drug program, and similar regimens proposed by

other administrations within the Department, will be

determined to be constitutional. The critical need for

properly-administered drug testing to ensure that em-

ployees in the transportation industry do not have drugs

or drug metabolites in their system while performing

sensitive safety- and security-related functions out-

weighs the reduced privacy interest of these employees.

Lack of Evidence of a Drug Problem in the Aviation

Industry. Nearly every commenter who opposes drug

testing in general, and random testing in particular, and

even commenters who support the comprehensive drug

testing proposals, raise the issue of lack of evidence of

a drug problem in commercial aviation. On this basis,

the commenters assert that the FAA can not justify the

comprehensive proposals contained in the NPRM. ALPA,

the Aircraft Owners and Pilots Association, (AOPA),

and the organizations representing flight attendants

maintain that the industry should police itself in the area

of drug use and abuse.

FAA Response. The FAA made no attempt to ob-

scure the lack of widespread evidence of drug use or

abuse among commercial aviation personnel. However,

after publication of the NPRM in the Federal Register

on March 14, 1988, federal investigators released prelimi-

nary data showing that the captain of Continental Air

Express Flight 2286, which crashed in Durango, Colo-

rado on January 19, 1988, may have been impaired by

drugs while operating the aircraft. A preliminary report

of the National Transportation Safety Board (NTSB)

indicates that toxicological test results show that the cap-

tain of Flight 2286 had cocaine and a cocaine metabolite

in his system at the time of the crash. Seven passengers

and the pilot and copilot died in the accident.

39a

In 1983, the NTSB issued an Aircraft Accident Re-

port (NTSB/AAR-84/11) on the crash of Central Air-

lines Flight 27 in Newark, New Jersey, on March 30,

1983. The NTSB determined that the probable cause of

the crash of the Gates Learjet nonscheduled, cargo-carry-

ing aircraft included “impairment of the flight crew’s

judgment, decisionmaking, and flying abilities by a com-

bination of physiological and psychological factors.” The

NTSB did not conclude that drug-impaired performance

was the sole cause of the crash. However, the report

does state that test results indicate that the captain had

used marijuana and the copilot had used, or been ex-

posed to, marijuana within the 24 hours preceding the

crash. Also, toxicological tests indicate that the co-

_ pilot’s urine showed evidence of contra-indicated use of

an antihistamine drug.

Additional evidence of illegal drug use by individuals

employed in the airline industry appeared in the fall of

1986, when a series of articles in the Pittsburgh Press,

based on interviews with emergency room’staffs at area

hospitals, highlighted 23 cases of airline flight crew drug

abuse. Twenty of those cases involved cocaine overdoses,

two were heroin reactions, and one dealt with valium and

alcohol. Twelve cockpit crewmembers and eleven cabin

crewmembers were among those treated by Pittsburgh

area hospitals also indicated that they had treated nu-

merous cases of drug abuse among non-flight employees,

such as mechanics. The Pittsburgh Press also, surveyed

17 drug treatment clinics across the country and found

that more than 69 pilots had been treated for cocaine ad-

diction. A subsequent FBI investigation of drug use in

the Pittsburgh area produced evidence that a number of

airline ernployees, including cockpit, cabin, and ground

crewmembers, had used cocaine, marijuana, and other il-

legal drugs, sometimes on duty or shortly before report-

ing for duty.

The NPRM also included comments by a Part 121 and

Part 135 certificate holder that implemented an unan-

“40a

nounced drug testing program applicable to its employ-

ees. This company reported that 2.5 percent of its 180

pilots and 4 percent of its 240 mechanics tested positive

for a trace, or more, of illegal drug in their system.

Data from the airline industry regarding preemployment

screening of applicants for various positions indicate that

the number of positive drug tests ranges from 4.2 per-

cent to 20 percent with results as high as 25 percent to

30 percent in some geographical locations.

Although this data does not show an overwhelming

drug problem in commercial aviation, it does show con-

crete evidence of drug use in the commercial aviation

sector. The FAA recognizes that commercial aviation

personnel operate in a professional and highly-regulated

environment. Howevér, pursuant to the FAA’s statu-

tory mandate to ensure aviation safety, the FAA also

must acknowledge that commercial aviation personnel

are not immune to, nor insulated from, drug use or

abuse that may affect safety-critical job performance.

The FAA believes that any drug use in commercial avia-

tion warrants preventive and proactive intervention by

the FAA to ensure aviation safety. The FAA believes

that this view is not inconsistent with the increasing

awareness of several aviation employers who currently

have, as disclosed in their comments, basic drug testing

and employee rehabilitation programs for their employ-

ees.

Although not a universally-expressed opinion among

the commenters, ATA “fully embrace[s] the philosophy,

expressed in the NPRM, that individuals who wish to

work in aviation activities that involve the safety of

passengers, co-workers, and others must not use illicit

drugs, even while off-duty.” Several commenters, in-

cluding RAA, note that to the extent any drug use is

occurring in the aviation industry, it is a “safety issue

and it is well within the purview of the FAA to develop

a comprehensive, nationally applicable set of regulations.”

4la

The Equal Employment Advisory Council (EEAC) be-

lieves that the workplace is an appropriate environment

to intervene in the process of individual substance abuse.

EEAC also believes that the FAA has correctly concluded

that the purpose of drug testing is not to determine that

an employee is impaired by drugs at the time of testing.

Instead, testing is used to enable an employer rationally

to determine if an employee has used drugs and to con-

clude reasonably that there is a possibility of future im-

pairment based on subsequent use.

Comments that the Proposed Rules are Politically-

Motivated. The FAA received many comments that state

that the comprehensive anti-drug program proposed by

the FAA is based solely on political perceptions and

goals. The commenters stress that DOT and the FAA

have surrendered to the public hysteria over drug use

and unfavorable press reports of drug use in the avia-

tion industry.

FAA Response. Because this issue is raised so fre-

quently by the commenters, the FAA chooses to address

these comménts although they are beyond the scope of

the rulemaking. The war against drugs is one of this

Administration’s top priorities. Also, Congress has en-

acted a substantial amount of legislation to address the

use, distribution, importation, and interdiction of drugs

in the United States and is considering enactment of ad-

ditional legislation. Moreover, a significant number of

public opinion polls indicate that the American public

is deeply concerned about the effect of drug use by in-

dividuals in critical safety occupations, including avia-

tion. The fact that the Administration, Congress, and

the public are concerned about drug use is noteworthy.

However, the FAA is issuing the comprehensive anti-

drug program in this final rule because it is consistent

with the FAA’s statutory duty to promulgate minimum

standards to ensure and promote aviation safety.

42a

DHHS Guidelines. The FAA received numerous com-

ments, including comments from drug testing laboratories

and companies supplying drug testing equipment on the

guidelines for drug testing promulgated by the Depart-

ment of Health and Human Services (DHHS). Many of

the commenters state that the certification requirements

for drug testing laboratories are too rigid because the

DHHS guidelines require laboratories to have the capa-

bility to do both initial and confirmation testing at the

same laboratory site. The Director of the Santa Maria

Public Airport District and Psychemedics Corporation, a

commenter at the San Francisco public hearing, suggest

that the FAA use analysis of hair, in lieu of urinalysis

testing, to test for drugs on the basis that hair analysis

may be more accurate and more reliable. Psychemedics

Corporation proposes that analysis of hair samples would

produce more complete results because hair contains a

“longitudinal” history of drug use that could reveal drug

use in excess of 90 days before analysis. This commenter

also notes that the two-step process of immunoassay and

GC/MS analysis would still be used; the only change

would be the material that was analyzed. Federal Express

strongly opposes implementation of the DHHS guidelines

because they are overly-burdensome on carriers with op-

erations in mulitple locations.

Some commenters also state that a split sample should

be obtained from each individual in order to ensure the

accuracy of the analysis. Sever2] commenters raise the

issue that specimens may be used by an employer to test

for physiological states, including epilepsy and pregnancy,

to discriminate against applicants and employees. A few

commenters consider the requirement of “‘monitored”’ speci-

men collection, whether by listening to or directly observ-

ing an individual, to be embarrassing and intrusive.

The AMA opposes the proposal to require employers to

comply with the DHHS guidelines. The AMA states that

these requirements would result in an undue hardship

RETF Oe a ee

po

En ee A

48a

on aviation medical examiners who must comply with

chain-of-custody procedures designed to ensure the integ-

rity of the specimen.

The NTSB strongly concurs in the requirement that

drug testing laboratories that analyze specimens pursuant

to the drug testing program must meet the scientific and

technical DHHS guidelines and must be certified by the

Department of Health and Human Services. Insofar as

the DHHS guidelines are inconsistent with other NTSB

comments, the NTSB recommends that the FAA revise the

guidelines for the industry drug testing program. ATA

agrees that only DHHS-approved labs should be used for

analyzing specimens but that the DHHS guidelines should

be tailored to accommodate the particular needs of the

aviation industry.

The SYVA Company and Drug Screening Systems, Inc.

submitted comments to the FAA on the DHHS guidelines.

Both companies are involved in the manufacture and sup-

ply of drug screening systems and equipment. These com-

panies urge caution in the FAA’s proposal to adopt the

DHHS guidelines based on the restrictive and possibly

burdensome nature of the requirements on employers re-

quired to conduct drug tests pursuant to the rule. These

companies address several issues, including batch re-

quirements, on-site collection, threshold drug levels, and

development of new testing procedures not permitted un-

der the current DHHS guidelines.

IFFA feels strongly that the Xnzyme Multiplied Im-

munoassay Technique (EMIT) test should not be used

as part of laboratory analysis of specimens because the

test detects only the presence of a drug metabolite of the

active drug and it often results in false-positive results.

false-negative results, or misidentified results.

ALPA generally supports the proposal to make the

DHHS guidelines applicable to collection and analysis of

specimens. However, ALPA believes that the FAA’s reg-

44a

ulation should contain additional employee safeguards.

First, the regulation should require split samples during

collection. Second, the regulation should require that

threshold drug levels determined by a confirmation test be

consistent with the initial test to account for quantitative

discrepancies in test results that are not attributable to

deterioration of the sample. Third, ALPA suggests that

an employee should be able to present the results of an

independent test result to an MRO during review of test

results to determine the validity of a positive test result.

Fourth, the regulation should allow labor and manage-

ment, through collective bargaining, to inspect labora-

tories and to perform quality control and administrative

functior 3 related to any anti-drug program.

Labor unions, including TWU and the Teamsters Union,

advocate development and implementation of separate or

additional guidelines to safeguard the selection and per-

formance of laboratories analyzing specimens for drugs

or drug metabolites.

EEAC believes that the DHHS guidelines are a valuable

contribution to the goal of establishing procedural norms

in collection and testing of specimens. However, EEAC

believes that employers should establish individual pro-

cedures to ensure the integrity of a sample and its anal-

ysis. EEAC emphasizes that it is inappropriate for the

FAA to impose such detailed requirements on private

employers.

FAA Response. In the NPRM, the FAA proposed that

all collection of specimens and drug testing take place in

accordance with the “Mandatory Guidelines for Federal

Workplace Drug Testing Programs” published by the De-

partment of Health and Human Services (53 FR 11970;

April 11, 1988). The DHHS guidelines describe the col-

lection and testing procedures applicable to all drug test-

ing in the Federal government, and they include safe-

guards for the accuracy and privacy of collection and

testing.

45a

The Department of Transportation has determined

that certain modifications of the DHHS guidelines are ap-

propriate in the context of this and other DOT-operating

administration drug-free workplace regulations. The re-

sult will be the DOT “Procedures for Transportation

Workplace Drug Testing Programs,” which will be codi-

fied at 49 CFR Part 40. These DOT procedures are in-

tended to preserve, to the greatest extent praticable, the

important safeguards provided by the DHHS guidelines.

Some of the modifications to the DHHS guidelines will

be editorial in nature (e.g., references to responsibilities

of “agencies” are changed to references to “employers”).

Other modifications are intended to take into account dif-

ferences in the situations, of Federal agencies and DOT-

regulated industries. For example, in testing at remote

sites, DOT-regulated industries may find it necessary to

conduct come kinds of testing in medical facilities or

through the use of mobile units, rather than the more

permanent collection sites contemplated by the DHHS

guidelines. It may not be practicable for regulated em-

ployers to maintain on-site permanent logbooks. Conse-

quently, the DOT procedures would permit alternative

collection and recordkeeping procedures in these circum-

stances.

The Office of the Secretary in the Department of Trans-

portation will publish elsewhere in today’s Federal Regis-

ter an interim final rule with request for comments en-

titled, “Procedures for Transportation Workplace Drug

Testing Programs,” that will codify the Department of

Health and Human Services guidelines for drug testing

at 49 CFR Part 40. This new part will set forth require-

ments for such things as specimen collection procedures,

laboratory procedures, and quality assurance and certifi-

cation procedures. The rule will provide guidance on how

this rule shall be implemented.

During the comment period on the FAA’s NPRM, and

those rules proposed by other DOT operating administra-

46a

tions, comments were received concerning the DHHS

guidelines. These comments are noted in this preamble

and also will be transferred to the Department of Trans-

portation to be incorporated in the docket for the Office of

the Secretary (OST) interim final rule creating 49 CFR

Part 40. OST will respond te those comments, as well as

comments received during the comment period for Part

40, in its notice following the end of that comment period.

The FAA proposed only urine testing in the proposals

contained in the NPRM. The suggestion of drug testing

using analysis of hair specimens raises an issue within

the expertise of the Department of Health and Human

Services. Thus, at this time, DOT and the FAA do not

intend to deviate from urinalysis as the technique for

determining the presence of drugs or drug metabolities in

an employee’s system.

The FAA acknowledges the AMA comments regarding

the inability of all aviation medical examiners to comply

with the collection and chain-of-custody procedures con-

tained in the DHHS guidelines due to the lack of appro-

priate facilities for collection. The FAA does not agree

with the AMA that the requirements are overwhelming

or overly-burdensome. Although the AMA was not spe-

cific regarding its objection to the collection and chain-of-

custody procedures, DOT has included provisions in the

DOT procedures to address some of the difficulties associ-

ated with collection and chain-of-custody procedures that

may not have been appropriate for private entities. How-

ever, the FAA and DOT believe that strict collection and

chain-of-custody procedures are critical to ensure the in-

tegrity and identity of a specimen provided by an em-

ployee. Thus, DOT has retained these protections in its

modification of the DHHS guidelines. Moreover, only

those aviation medical examiners who choose to provide

this service to commercial aviation personnel during a

physical examination are required to conform to the mini-

mum procedures cortained in the DOT procedures.

47a

Consistent with the suggestion of the NTSB and other

commenters, the Department of Transportation will

modify the DHHS guidelines to tailor the provisions for

application by private entities. The DOT procedures wil!

not modify the basic, technological aspects of the rule

(e.g., DHHS certification of laboratories, testing method-

ologies, collection procedures, and chain-of-custody pro-

cedures). Any arguably substantive changes from the

DHHS guidelines will be included only to reduce prac-

tical and administrative burdens on private entities. These

changes will be discussed in an ancillary document pub-

lished by the Department of Transportation in the Federal

Register. DOT and the FAA believe that the DOT pro-

cedures will provide adequate and appropriate procedures

for collection and testing of samples. Although the FAA

anticipates that the DOT procedures will prove to be an

effective and efficient method of collection and testing, ex-

perience under the testing program or a change in the

circumstances or needs of the industry may warrant fur-

ther regulatory revisions in the future.

Accuracy of Drug Test Results. Many commenters base

their opposition to drug testing on the perceived inac-

curacy of analysis and test results. The commenters in-

clude the issues of false-positive test results, passive in-

halation of illicit drugs, misidentification of licit drugs,

and ingestion of food substances, including poppy seeds,

resulting in a positive drug test result.

FAA Response. The FAA is aware of these expressed

concerns because each of these issues surfaced in the early

1980s with the first series of drug testing programs intro-

duced in the military and the private sector. In the early

years of drug testing and analysis, laboratory security

and analytical procedures had not reached today’s level of

sophistication. False-positive test results occur primarily

in analysis of a specimen during an initial screening test.

although contemporary screening tests, such as immuno-

assay tests, have become extremely accurate and approach

48a

99 percent accuracy levels. Despite its increased accuracy,

the initial screening test remains a less expensive test

used only to yield a preliminary indication of the possible

presence of drugs or drug metabolites. In order to ensure

the integrity and accuracy of any test result, each positive

initial screening test result must be confirmed using GC/

MS analysis or another confirmatory procedure that may

be subsequently approved by DHHS and incorporated into

the DOT procedures. The GC/MS confirmation test is an

extremely accurate and sophisticated test and is virtually

error-free when used in compliance with the DHHS guide-

lines. The DOT “Procedures for Transportation Work-

place Drug Testing Programs” (49 CFR Part 40), will

be essentially identical to the ““Mandatory Guidelines for

Federal Workplace Drug Testing Programs” published

by the Department of Health and Human Services on

April 11, 1988.

Employers must comply with the DOT procedures when

conducting a testing program pursuant to the final rule.

Like the DHHS guidelines, the DOT procedures will pro-

vide a system of checks and balances during collection and

analysis of specimens. This system ensures the integrity

and accuracy of the tests using appropriate. scientific

methods and rigid chain-of-custody procedure. An em-

ployer may only use a laboratry that complies with the

DOT procedures. Also, an employer may only use a labor-

atory that has been certified by DHHS to process and

analyze specimens required by the FAA rule. The DOT

procedures regarding testing methodologies and- technical

matters will be identical to the DHHS guidelines. Thus,

employers will be able to use any DHHS-certified labora-

tory since the laboratories will not tiecessarily be required

to use different analytical techniques and testing method-

ologies for different entities conducting testing. The De-

partment of Transportation expects that sufficient labora-

tories will have been certified for drug analysis by the

Department of Health and Human Services by early

49a

1989. However, the FAA will extend the compliance dates

contained in this final rule if DHHS has not certified a

sufficient number of laboratories to efficiently and accu-

rately process and analyze specimens pursuant to the re-

quirements of this final rule.

Since the mid-1980s, laboratories have become increas-

| ingly sophisticated in their analytical methods and chain-

t of-custody procedures. Many laboratories have compiled

4 extensive records demonstrating scientific accuracy and

f protection of individual specimens. For example, Compu-

Chem Laboratories, a major drug testing laboratory, has

analyzed over 500,000 urine samples, conducting discrete

testing for nine different drugs which resulted in nearly

five million distinct analyses of these specimens, since

1980. CompuChem also has analyzed approximately

- 750,000 urine samples for the presence of two different

drugs, resulting in nearly 1.5 million analyses of these

specimens, pursuant to its contract with the military.

None of the over six million analyses performed for DOT,

the military, and other private and public entities has

resulted in a false-positive test result.

In late 1987, a CompuChem clerical worker incorrectly

labeled two samples that belonged to DOT employees.

Within hours after the test results were questioned by the

medical review officer, CompuChem and the medical re-

view officer had identified and corrected the error. Compu-

Chem was not satisfied with its prompt resolution of the

error. As stated in its comment to the NPRM, Compu-

Chem has instituted an additional system of review, by

CompuChem personnel and computer checks, to ensure

that “* * * this one in a million error will not reoccur.”

Another drug testing firm, PharmChem Laboratories,

has conducted over eight million nonmilitary drug tests

nationwide. In its statement to the FAA during the

public hearing held in San Francisco on June 9, 1988,

PharmChem notes that several courts have determined

that the GC/MS confirmation test is “virtually 100 per. .

50a

cent accurate, assuming that proper chain-of-custody pro-

cedures are followed.”

The FAA does not believe that the issue of “passive

inhalation” of marijuana smoke will prove to be a sig-

nificant issue leading to false-positive test results. First,

PharmChem’s statement indicates that the DHHS thresh-

old levels that would result in a positive drug test result

for the presence of marijuana or marijuana metabolites

(to be incorporated completely and without change in the

DOT procedures) are set at a level sufficiently high to

preclude the possibility of a positive test result based on

passive inhalation of marijuana smoke. Second, studies

conducted to simulate the conditions that result in passive

inhalation have been conducted in artificially-devised and

extremely confining areas that were poorly ventilated.

Also, in order to obtain a positive test result, testing was

conducted immediately after this prolonged and intensive

exposure to the marijuana smoke. Based on the FAA’s

knowledge of these studies, the FAA has concluded that

it is highly unlikely that the identical circumstances would

be encountered or accurately reproduced outside a la-

boratory.

Finally, the FAA believes that the safeguards that will

be provided in the DOT procedures and by the medical

review officer (MRO) review process, which are essen-

tially identical to the DHHS guidelines, will preclude mis-

identification of food substances or licit drugs that might

produce a false-positive test result. The DOT procedures

will provide an individual with an opportunity to report

any legal or prescription drugs that he or she may be

taking at the time of collection of the specimen. The

MRO’s broad authority to interpret each confirmed posi-

tive test result, to evaluate an employee based on the

MRO’s knowledge of drug abuse disorders, and to verify

that a confirmed positive test result is accurate should

preclude misidentification of food substances or licit drugs

taken in accordance with a valid prescription. In sum-

5la

mary, the FAA believes that the two-step testing process,

coupled with the DOT procedures, provides a process by

which an individual is protected from erroneous false-

positive drug test results.

Preemployment Testing. Most organizations and indi-

viduals do not object to the concept of preemployment test-

ing. AOPA supports preemployment testing at the dis-

cretion of the employer. Operators who hire pilots or

crewmembers pursuant to short-term contracts believe

that a preemployment test is burdensome if required each

time a pilot is rehired pursuant to a new contract. These

entities suggest that preemployment tests be given only

at the time of training or placement on a bid list for

contracts.

Suburban Airlines has required preemployment testing

of all flight crew applicants for over a year. Suburban

supports 100 percent preemployment testing of the avia-

tion employees proposed in the NPRM. The Director of

the Santa Maria Public Airport District also supports

preemployment testing and suggests that preemployment

testing be implemented immediately.

The Soaring Society of America (SSA) believes that

small business employers should have the option of re-

quiring preemployment drug testing as a condition of

employment. SSA feels that preemployment testing should

be optional because applicants can circumvent detection

in a preemployment drug test merely by abstaining from

drug use for a short period of time before the pre-

employment test.

FAA Response. The FAA believes that preemployment

testing is a necessary component of an effective anti-

drug program. Pursuant to the rule, a preemployment

drug test is required only when an applicant has been

selected for employment in a sensitive safety- or security-

related position with the employer. The preemployment

testing provision does not require an employer to test each

52a

aprlicant for a sensitive safety- or security-related posi-

tion. The rule simply states that an employer may not

hire an applicant to perform sensitive safety- or security-

related functions unless the applicant has passed a drug

test. Therefore, the employer need only test an applicant

before actually hiring the applicant for a sensitive safety-

or security-related position.

The FAA has revised the proposed rules in ways which

should ease the burden on operators who frequently re-

hire employees pursuant to short-term contracts. The

FAA believes that the central issue regarding the fre-

quency of preemployment testing is the continuity of an

employee’s involvement in an employer’s drug testing

program. An employer is required to conduct a pre-

employment test only the first time that an employee is

hired pursuant to a contract with that employer so long

as the individual remains in the employer’s program, even

during periods between contracts. The individual, thus,

would be subject continuously to drug testing. In addi-

tion, so long as an employee is subject to an FAA-

approved anti-drug program, another employer may use

that employee to perform sensitive safety- or security-

related functions. Thus, an individual who participates

through a consortium would be able to provide services

on a contract basis to multiple employers without having

to submit to subsequent preemployment tests or to par-

ticipate in another employer’s drug testing program. If

an employee has not been continuously subject to an

FAA-approved anti-drug program, an employer would

be required to conduct a preemployment drug test.

In the FAA’s opinion, it would be permissible for an

employer to allow a contract employee to continue in the

employer’s anti-drug program after termination of a

contract. Particularly in the case of an employer who

hires employees pursuant to a series of short-term con-

tracts, both the employer and the employee benefit if the

employee is continuously subject to a drug testing pro-

58a

gram. The employer could “rehire” the employee at any

time but would not be required to give the employee an-

other preemployment drug test. In addition, the employee

could perform sensitive safety- or security-related func-

tions for another employer on a temporary basis but

would not be required to participate in another employ-

er’s anti-drug program or to submit to anti-drug pro-

gram or to submit to another preemployment drug test.

To the extent that the employee is not covered by an

FAA-approved anti-drug program, an employer would be

required to conduct a preemployment drug test before the

employee could be hired by a subsequent employer or re-

hired by a previous employer.

Periodic Testing. AOPA believes that periodic drug

testing should not be part of an employer’s drug testing

program but should only be conducted based on the rea-

soned judgment of an aviation medical examiner. RAA

supports periodic testing during medical certification at

least once each calendar year. RAA believes that the em-

ployee should bear the cost of the periodic test. Federal

Express does not oppose periodic testing but believes that

it should be unrelated to the FAA medical examination.

The AMA opposes periodic drug tests as part of a

routine medical examination because compliance with col-

lection and chain-of-custody procedures, such as those con-

tained in the DOT procedures and the DHHS guidelines,

would be an undue burden on aviation medical examiners.

ATA stated that its association is not convinced that

periodic testing effectively deters illicit drug use because

of the relative ease with which this test can be circum-

vented by abstinence. SSA generally does not endorse

periodic testing because an employee can avoid detection

by relatively short-lived abstinence before any announced

periodic test.

FAA Response. The FAA agrees with the commenters

that announced periodic testing can be circumvented by

54a

an employee’s abstinence from drug use. However, peri-

odie testing does enable an employer to identify those

employees who are so heavily-dependent on drugs that

they are unable to abstain from drug use for even a short

period of time prior to a periodic test.

The FAA has modified the periodic testing require-

ment of the regulation. Under the proposed regulation,

an employee who holds a medical certificate would have

been required to submit a specimen for drug testing as

part of each medical examination required pursuant to

Part 67. The revised section makes it clear that an indi-

vidual is required to submit a specimen for drug testing

during the first medical examination of the employee dur-

ing the calendar year after implementation of the anti-

drug program. Therefore, pilots who hold Class I medi-

cal certificates, who are required to have periodic medical

examinations at 6-month intervals, must be tested only

once during one of the medical examinations of the year

pursuant to the anti-drug program.

The revised section also states that an employer may

discontinue periodic testing after the first year of pro-

gram implementation when the employer has implemented

its random testing program according to the implementa-

tion schedule and, therefore, is conducting a significant

number of random tests. The periodic testing require-

ment will ensure that all current employees who hold

medical certificates will be tested once during the first

year of implementation of an employer’s anti-drug pro-

gram; most of the employees who hold medical certificates

also will be subject to random selection for testing during

part of the first year of implementation. The majority

of random testing programs will be operational after the

first year of implementation and periodic testing, which

is less effective than random testing, will no longer be a

necessary component of an employer’s anti-drug program.

The FAA anticipates that these revisions will provide

maximum drug detection capability and ease the transi-

55a

tion to a full random testing program. The FAA con-

siders the revision to be appropriate to relieve some of

the significant economic and administrative burdens noted

by the commenters who believe that periodic testing is an

ineffective and ineffective drug deterrent.

Random Testing. Most individual commenters oppose

random testing for a variety of reasons. Among these

reasons is the lack of evidence of drug use or abuse in

aviation to warrant random testing, invasion of indi-

vidual privacy, and violation of constitutionally-protected

rights.

AOPA opposes random testing primarily on the basis

of the unsettled constitutional issues surrounding random

testing and the burden imposed by this testing method on

law abiding citizens. AOPA suggests that the FAA delay

promulgation of a final rule until the issues raised by

random testing are substantially resolved by the Supreme

Court in Railway Labor Executives’ Association v. Burn-

ley and National Treasury Employees Union v. von Raab

(cited previously). AOPA states that, by awaiting any

Supreme Court decision, the FAA could ensure that the

final rule is in conformity with guidance enunciated in

the Supreme Court’s opinion in Burnley and von Raab.

One commenter submitted comments individually, as na-

tional litigation counsel for AOPA, and on behalf of the

California Aviation Council and the Orange County

Aviation Association. This commenter states that the

NPRM is an unconstitutional invasion of privacy and a

violation of an individual’s procedural due process rights.

The commenter believes that the NPRM should be with-

drawn to await the Supreme Court’s impending decisions.

The AMA supported random testing only as part of

a comprehensive rehabilitation program. The AMA be-

lieves that random testing is not cost effective, is un-

necessarily intrusive, and, without confirmation testing,

random screening tests are inaccurate.

i

'

:

}

|

:

4

;

J

*

q

{

4

:

‘

:

56a

In addition to soliciting comments on the general con-

cept of random testing, the FAA solicited comments on an

appropriate random testing rate of up to 125 percent.

Several small business entities, including TEMSCO Heli-

copters, Inc., Henson Airlines, and Tramco, Inc., oppose

the random testing requirement based on the financial

and administrative burdens associated with a 125 percent

testing rate, transportation of employees to the collection

site, and replacement of personnel during testing.

TEMSCO Helicopters suggests that a random testing

rate of 10 percent will enabie the industry to determine

if there is a drug problem in aviation without overburden-

ing the industry. RAA also believes that a 125 percent

random testing rate is overreaching and unwarranted;

however, if the FAA proceeds with a random testing

provision, RAA suggests that a 50 percent random test-

ing rate is appropriate. Although Suburban Airlines

strongly supports random testing, Suburban believes that

a 50 percent random testing rate of the employees pro-

posed in the NPRM would relieve the unjustifiable eco-

nomic burden on a cost-benefit basis. ERA Aviation, Inc.,

a Part 121 and Part 135 certificate holder operating more

than 12 helicopters and 12 airplanes, believes that un-

announced random testing is the most effective deterrent

to drug abuse. However, ERA questions a requirement

to randomly test 125 percent of the employees on an an-

nual basis. ERA believes that random testing of 25

percent to 50 percent of the affected employee groups,

coupled with periodic testing, would provide a sufficient

deterrent to drug use if the penalties for positive test

results were severe.

NTSB opposes the random testing requirement of the

proposed rules. However, if random testing were included

in the final rule, the NTSB believes that a relatively high

random testing rate would be a more effective deterrent

to drug use. The acting Chairman of the NTSB did not

concur with the NTSB’s position regarding random test-

57a

ing; the acting Chairman supports random testing pro-

vided that the random testing rate is sufficiently high to

serve as a deterrent to drug use.

ATA, American Airlines, and Delta Airlines support

the FAA’s mandatory random testing provision because

it would provide the maximum deterrent effect to illicit

drug use. ATA supports a random testing rate of 50

percent based on a review of Department of Defense and

private industry drug testing programs. American Air-

lines also supports the mandatory random testing provi-

sion and a 125 percent random testing rate. A consultant

to American Airlines on the issue of drug abuse preven-

tion in the workplace, who submitted an affidavit attached

to comments by American Airlines, is convinced that ran-

dom drug testing is “the only powerful and proven means

of detecting drug use and drasticaily reducing drug use

and thereafter preventing further drug problems from oc-

curring.” On the other hand, Federal Express states that

random testing should be permitted, but not mandated,

by regulation. Federal Express states that if the FAA

ultimately mandates random testing, carriers should be

allowed to choose a random testing rate between 15 per-

cent and 50 percent. Federal Express also believes that

carriers should be free to set different random testing

rates for different groups of employees.

There was almost universal opposition to random test-

ing by unions and organizations representing employees.

ALPA, the Transport Workers Union of American

(TWU), and the International Brotherhood of Teamsters

(Teamsters Union) are ‘adamantly opposed to random

testing. ALPA (Council #12) concurs in ALPA’s gen-

eral opposition to random drug testing of professionals

in the aviation industry. The Teamsters Union states

that a drug testing program is a change in working con-

ditions which, in accordance with Federal labor law, is a

mandatory subject of collective bargaining.

ait ID tate

58a

SSA does not oppose random testing of employees. How-

ever, in order to provide a workable and effective anti-

drug program for small business, SSA suggests that en-

tities employing 12 or fewer full-time employees be ex-

empted from the random testing requirement. SSA de-

fines “full-time employees” as those individuals who work

for an employer at least 30 hours per week or 5 days per

week and have maintained that schedule for at least 90

days.

One commenter, who spoke at the San Francisco public

hearing on June 9, 1988, has been a practicing physician

for 24 years and has devoted the past seven years to the

exclusive practice of aviation medicine. This commenter

has worked regularly with EAP representatives and has

been involved with “* * * hundreds of airline employees

before, during and after treatment for drug and alcohol

dependencies.” Based on the commenter’s extensive ex-

perience in drug and alcohol use by aviation employees,

he observes that the present system of relying on “* * *

peer and supervisory identification, and a highly visible

employee assistance program,” and on a scheme of “pre-

employment for-cause and fitness-for-duty drug testing,

enables significantly impaired employees to remain in the

workforce.” Therefore, this commenter concludes that in

order to eliminate those remaining risks, “* * * there is

nothing more we can do short of random testing.”

FAA Response. While noting the constitutional issues

surrounding the issue of random testing discussed pre-

viously, the FAA continues to believe that unannounced

testing based on random selection is a fundamental com-

ponent of an effective drug testing program. Unan-

nounced, random testing has proven to be an effective de-

terrent to drug use and will provide safety benefits to the

aviation community by reducing or eliminating drug use

by sensitive safety- or security-related aviation personnel.

Unannounced, random testing programs initiated by the

military, including the Coast Guard, and private indus-

59a

try show declining drug use, evidenced by a decrease in

the number of individuals who test positive for drugs,

over the course of the drug testing program.

The FAA received many comments regarding the pro-

posed random testing rates. Several commenters suggest

a random testing rate of 125 percent because that rate

would result in the most significant deterrent to drug use

in the aviation industry. However, other commenters who

address this issue believe that a 125 percent random test-

ing rate would be excessive and would impose a significant

economic burden, particularly on small aviation businesses.

The commenters propose a range of random testing rates

starting at 10 percent annually. The majority of the

commenters suggest that an annual 50 percent random

testing rate for the aviation industry is appropriate. These

commenters believe that the 50 percent testing rate ac-

complishes several goals consistent with the intent of the

proposal.

In response to the commenters, the FAA has substan-

tially revised the random testing proposal in the NPRM

in order to reduce the practical and administrative bur-

dens associated with initiating an unannounced testing

program based on random selection of employees. The

FAA’s approach also is designed to provide a random

testing rate that balances cost effectiveness and burdens

on employees and employers but still results in an effec-

tive and credible deterrent to drug use.

For some employers, particularly those with a large

number of employees subject to drug testing, it may be

a substantial burden to move from no random drug test-

ing of employees directly to random testing of 50 per-

cent of the covered employees. For example, if required

to have tested 50 percent of all covered employees by the

end of the first year, employers might have to test at

rates far above a 50 percent rate toward the end of the

year, to make up for lower rates at the beginning of the

year. Employers should be permitted to start the pro-

oor

60a

gram at a lower testing rate and work up to a 50 per-

cent rate as experience is gained and the testing proce-

dure becomes administratively routine. The FAA does

not want te create a situation which might lead to in-

advertent © takes by requiring initial unannounced test-

ing based, -andom selection at too high a rate.

The final rule, therefore, provides an implementation

procedure that would allow employers to phase in unan-

nounced drug testing based on random selection of em-

ployees during the first 12 months in which tests are

required to be conducted. Employers would not be re-

quired to reach an annualized rate of 50 percent until

the last test collection of the first year of the program.

The total number of unannounced tests based on random

selection of employees during the first 12 months of the

employer’s testing program would have to equal at least

25 percent of the covered employee population. Also, the

employer is required to space the tests reasonably

throughout the year. This approach will provide a suffi-

cient level of deterrence to drug use and will permit the

employer to phase in the 50 percent rate.

Suppose, for example, that an employer has 1000 sensi-

tive safety- or security-related employees. At a 50 per-

cent annual rate, the employer would be required to con-

duct 500 unannounced tests based on random selection

during a year. Under the phased approach, however, the

employer could conduct only a few drug tests at the

beginning of the program and then gradually increase

the number of tests until, by the end of the first year,

the annualized rate of 50 percent was achieved. Thus, if

the employer’s drug testing plan contemplated adminis-

tration of unannounced tests based on random selection

on 12 occasions during the year, the employer would

need to collect 42 urine specimens for analysis (500

divided by 12) on the last occasion, bu* could collect

fewer specimens until then. Overall, the employer would

have to collect at least 250 specimens for analysis during

6la

the first year. In subsequent years, the employer is re-

quired to maintain the 50 percent annualized rate for

unannounced testing based on random selection of

employees.

The FAA believes that the final rule provides a moder-

ate, but substantial, level of testing based on random

selection that enables an employer to increase random

testing gradually during the first year of program im-

plementation. During subsequent years of the program,

the employer must maintain an annualized rate of 50

percent of the covered employees. In order to determine

the appropriate number of employees that must be tested

to reach the appropriate “annualized rate” for the ran-

dom testing program, the employer shall refer to the

number of employees subject to the rule at the beginning

of a calendar year.

At this time, the FAA believes that this phased pro-

gram, ultimately reaching a testing level equivalent to

50 percent of the covered program, ultimately reaching

a testing level equivalent to 50 percent of the covered

employees, will provide a sufficient deterrent to drug use

without imposing an undue economic or administrative

burden on employers and employees subject to the re-

quirements of the regulation. In addition, the program

will produce a sufficient data base at different annualized

rates and testing levels for the FAA to analyze the scope

of any drug problem in the commercial aviation industry

generally or within any particular sector of the commer-

cial aviation community. Analysis of the random drug

testing data submitted by an employer will allow the

FAA to determine if the random testing program should

be revised in any manner.

The phased program and the final 50 percent random

testing rate is consistent with the random testing pro-

gram currently applicable to safety- and _security-

sensitive employees of the Department of Transporta-

tion. DOT’s random testing program began in Septem-

62a

ber 1987; the random testing rate has gradually in-

creased and will reach an annualized rate of 50 percent

by October of this year. Data from September 1987 to

the present show that the current detection rate found

as a result of DOT’s random drug testing program is

0.83 percent; data from February 1987 to the present

show that the current detection rate for FAA and DOT’s

periodic (eg., scheduled) testing program is 0.012

percent.

According to the provisions of the final rule, all em-

ployers are required to randomly select a sufficient num-

ber of employees to enable the employer to conduct un-

announced testing of employees who perform sensitive

safety- or security-related duties for the employer at the

appropriate rate during the calendar year. In order to

conduct enough tests to reach the required percentage,

an employer may be required to select a number of em-

ployees who perform a sensitive safety- or security-

related functions for unannounced testing that is in ex-

cess of the actual number to meet the required percent-

age. Selection of a greater number of employees enables

the employer to reach the appropriate annualized rate

despite absences due to vacations and medical leave or

absences due to an inabil?ty to reach a collection site

resulting from travel or duty requirements.

If a consortium has been established among employers

or operators, the consortium would be required to select

and to test the appropriate rate of the aggregate total of

employees subject to the final rule who are covered by

the consortium. The testing rate of the consortium will

be attributed to each employer participating in the con-

sortium. In the FAA’s opinion, the consortium’s testing

rate can be attributed to each participating employer,

although less than the appropriate percentage of the

employees of a particular employer has been tested dur-

ing a calendar year, without significantly decreasing the

deterrent effect of a random testing program. An em-

63a

ployer or consortium that develops a random selection

scheme involving preliminary selection criteria, such as

ical zones, must specify these schemes or varia-

tions in the employer’s anti-drug plan. The FAA realizes

that these variations may provide administrative ease for

an employer. However, the FAA must review these

variations to ensure that the scheme does not dilute the

required annualized rate required by the final rule.

The FAA received comments from small aviation busi-

nesses regarding the difficulty of testing a large number

of employees on a random basis during the first year of

implementation of the rule. In response to these com-

ments, the FAA substantially revised the provisions of

the proposed rule. Certain Part 135 certificate holders

whose total workforce indicates 11 to 50 sensitive safety-

or security-related employees are given additional time

to submit a random testing plan and to ensure that the

appropriate percentage of the sensitive safety- and

security-related employees are subject to unannounced

drug testing on a random selection basis during a calen-

dar year. The FAA encourages these employers to de-

velop a comprehensive random testing plan as soon as

possible. As discussed later, Part 135 certificate holders

that employ 10 or fewer covered employees and those

individuals or entities listed in § 185.1(b), who are other-

wise exempt from the requirements of Part 135 but are

included in the final rule because they are engaged in

operations for compensation or hire, are given additional

time to develop and implement an anti-drug program

that includes random testing. The FAA notes that the

final rule does not restrict the ability of these employers

to submit a random testing program, and to implement

that program, earlier than the timeframes contained in

the final rule.

Some commenters address the issue of the difficulty in

developing an efficient and successful random testing

A i i ete

64a

program. The FAA notes that the rule provides flexi-

bility to an employer to begin the random testing pro-

gram at a lower random testing rate so long as the

required percentage of covered employees have been se-

lected on a random basis and have been tested by the

end of the first year after approval of the employer’s

anti-drug program or random testing plan. For exam-

ple, an employer may test small increments of employees

at the beginning of a period and may test a large per-

centage of employees at the end of the same period to

achieve the annualized rate that is required by the final

rule.

Postaccident Testing. AOPA supports postaccident

testing if it is conducted by the NTSB. AOPA believes

that postaccident testing should not be a part of an em-

ployer’s drug testing program and should not be con-

ducted by the FAA.

The NTSB comments that the 24-hour period pro-

vided for postaccident testing is excessive. The NTSB

recommends that the FAA specify a maximum period

of four hours for collection of a postaccident drug test

and provide an appropriate penalty for failure to collect

the specimen within the 4-hour period. The NTSB be-

lieves that delays of more than four hours in sample

collection impair detection of a drug and its “psychoac-

tive component(s)” in blood samples, particularly sub-

stances such as cocaine, marijuana metabolites, some

amphetamines, and phencyclidine (PCP). The NTSB

also suggests that blood testing is the preferable method

for postaccident testing and suggests that the FAA per-

mit this method of testing for the presence of drugs after

an accident. ATA also suggests that postaccident testing

should be conducted within 4 hours after an accident

and, in no case, later than 12 hours after an accident.

ATA recommended that the NTSB’s definition of ‘“‘in-

cident” should be added to the postaccident testing pro-

vision to cover situations when an aircraft is empty or

654

when personal injury or physical damage is less severe

than specified in the postaccident testing provision. ATA

also believes that postaccident testing should be con-

ducted unless a supervisor determines that an employee’s

drug use was not a contributing factor in the accident.

FAA believes that postaccident testing is “wasteful and

intrusive” unless the accident clearly is caused by the

person to be tested and there is individualized probable

cause to believe that the employee was impaired at the

time of the accident.

SSA does not completely endorse postaccident testing

based on a variety of practical considerations that SSA

believes are unresolved in the regulation as proposed.

However, SSA states that postaccident testing, after an

NSTB-defined accident, of any employee working for a

small business should be conducted as deemed feasible by

the employer. SSA believes that postaccident testing

should be conducted within 24 hours if the employer de-

termines that testing is feasible and appropriate. Also,

if the employer determines that testing is not feasible,

the FAA may request an explanation from the employer

during the routine investigation of the accident.

FAA Response. In the NPRM, the FAA proposed that

postaccident tests be conducted within 24 hours after an

accident based on the possibility that difficulties may arise

after an accident in transporting an individual to a col-

lection site or bringing a drug testing kit to the scene of

the accident. The FAA is aware that extended delays in

sample collection and testing after an accident may re-

sult in deterioration or elimination of a drug or a drug

metabolite from a person’s system. Recognizing these dif-

ficulties and concerns, the FAA has modified the post-

accident testing provision. Under the final rule, an em-

ployer must conduct postaccident testing of an employee

as soon as possible after the accident but in no case later

than 32 hours after the accident. Selection of this time

period comports with the DOT’s postaccident drug test-

66a

ing program for DOT employees, which provides a maxi-

mum of 8 hours to determine if an employee is required

to be tested and an additional 24 hours to actually ob-

tain a sample for testing.

The FAA strongly encourages employers to promptly

determine if an employee is subject to postaccident test-

ing, particularly in cases where there is little or no un-

certainty that an employee’s performance was a con-

tributing factor in the accident. The FAA intends to

vigorously enforce the regulation where there is unreason-

able delay in determining whether an employee should be

tested under this provision or where there is unreasonable

delay in testing after the determination to test is made.

Although several commenters who address the issue sug-

gest time periods of less than 24 hours, it is the FAA’s

opinion that a maximum period of 32 hours is a workable

and reasonable accommodation that is appropriate for the

aviation industry.

The NTSB’s suggestion that the FAA require an em-

ployer to conduct postaccident testing within four hours

after an accident is based on the time-sensitive nature of

toxicological testing of blood samples. On the other hand,

urinalysis testing does not involve the extreme time-

critical considerations associated with collection and test-

ing of blood samples. In the FAA’s opinion, postaccident

urinalysis testing is sufficient at this time to provide an

indication of an individual’s drug use that may have

been a causal factor in an aviation accident.

Also, the FAA proposed only urine testing in the

NPRM, specifically excluding blood testing as an option,

for all drug tests that would be conducted under the anti-

drug program. Therefore, the FAA considers the NTSB’s

suggestion to be beyond the scope of the notice and the

FAA has not adopted NTSB’s suggestion to permit post-

accident testing by collecting a blood sample. In the

aviation context, the significant proportion of serious ac-

cidents involving fatalities to crewmembers provides data

67a

with respect to drug involvement in those accidents. In

the FAA’s judgment, extending full toxicological testing

to surviving crewmembers is not warranted at this time.

Presently, the FAA is not convinced that including

the NTSB’s definition of “incident” as a trigger for drug

testing is warranted. As discussed below, the FAA be-

lieves that the revisions to the section providing for test-

ing based on reasonable cause will adequately address

circumstances that might qualify as “incidents.” The

current provisions allow sufficient, but limited, latitude

to an employer to determine whether an employee should

be tested following an incident or an accident not cov-

ered by the NTSB’s definition of accident.

Although several commenters suggest that the FAA

expand the scope of the postaccident testing provision,

the FAA believes that the postaccident testing provision,

limiting testing to only those employees whose perform-

ance may have been a cause of the accident, is appropri-

ate. The FAA believes that it is inappropriate to require

postaccident testing of an employee whose performance

could not have been a cause of the accident merely be-

cause that employee happens to have been onboard or in-

volved with an aircraft involved in an accident.

Testing Based on Reasonable Cause. The NTSB sug-

gested that the FAA include “incidents,” as defined by

the NTSB’s rules, as events that would trigger reason-

able cause testing. RAA agrees with the requirement

that two supervisors, one with training in the symptoms

of drug abuse, must concur in the decision to test an

employee based on reasonable suspicion of drug use.

RAA believes that each carrier should determine the

conditions which constitute reasonable suspicion. FEIA

also believes that two supervisors, trained to detect symp-

toms of drug abuse, must concur in all decisions to test

based on probable cause. ATA suggests that only one

supervisor be required to trigger testing an an employee

based on reasonable cause. In addition, ATA states that

68a

supervisors should not be required to have specialized

training for the purpose of determining when reasonable

cause exists to test an employee.

Tramco, Inc. believes that the proposed circumstances

that would support a decision to test based on reasonable

cause are too restrictive. Tramco believes that an em-

ployee’s attendance patterns, tips from coworkers, “error

rates,” and other indirectly observable indications should

also trigger testing based on reasonable cause. Tramco

currently uses these triggers in its drug testing pro-

gram; Tramco believes that the FAA’s criteria will not

result in detection of possible drug users because it is

limited to physical and observable indices of gross im-

pairment. SSA supports “for-cause” testing, as the em-

ployer deems necessary and feasible, if testing is con-

ducted pursuant to the DHHS guidelines.

IAM and TWU believe that the criteria that would

trigger testing based on reasonable cause are ill-defined.

These organizations believe that testing based on reason-

able cause will be a tool for employee harassment; these

organizations suggest that supervisory personnel should

be trained to recognize the symptoms of drug impair-

ment or that at least one of the supervisors making the

determination to test should be someone other than the

employee’s immediate supervisor. The Teamsters Union

and IAM believe that decisions and determinations re-

lated to testing based on reasonable cause should be docu-

mented and supported in a written report.

The Newton Psychological Centre submitted a “basic

identification profile,” developed to aid supervisors of the

Philadelphia Electric Company in identification of em-

ployees who may not be fit for duty. The profile is used

to detect early warning signs of problems based on medi-

cal or psychological problems. The profile sets forth be-

havioral, emotional, physical, biological, and cognitive

cues related to the use of marijuana, cocaine, alcohol,

barbiturates, am;yhetamines, and heroin, or cues related

SO ae Les ee ed

69a

to anxiety or depression. The company’s policies regard-

ing alcohol and substance abuse, job performance warn-

ing signs, and counseling and confrontation guidelines

are printed on the profile.

FAA Response. As stated in the FAA’s response to

comments submitted on the postaccident testing provi-

sion, the FAA is not including a “postincident” testing

provision at this time. However, the circumstances under

which a supervisor could require an employee to submit

to a test based on reasonable cause have been modified in

the final rule. Based on the comments submitted, par-

ticularly by employers who have existing “reasonable

cause” testing programs, the FAA has expanded the list

of circumstances that might trigger testing under this

provision. Evidence of repeated errors on the job, regula-

tory or company rule violations, or unsatisfactory time

and attendance patterns, if coupled with a specific, con-

temporaneous event that indicates probable drug use,

could provide additional, cumulative evidence to support a

decision to test an employee based on reasonable cause.

As proposed in the NPRM, an employer is permitted to

test a specimen provided by an employee, collected pursu-

ant to a reasonable cause determination, for the presence

of any drug or drug metabolite listed in Schedule I or

Schedule II of the Controlled Substances Act. The em-

ployer may test for these drugs, as part of the employer’s

approved anti-drug program, if the employer has specific

approval from the FAA to include these controlled sub-

stances in the employer’s anti-drug program. In addition,

the testing for these additional drugs must be conducted

in accordance with the DOT procedures to be codified in

49 CFR Part 40.

The FAA believes that the provision requiring two

supervisors, one of whom has specialized training in de-

tecting the symptoms of drug use, to concur in the deci-

sion to test an employee based on reasonable cause is

appropriate for large companies. However, the FAA has

70a

revised this section of the rule in order to address the

legitimate concerns of small employers, many of whom do

not have more than one supervisor employed at the com-

pany. For companies that employ 50 or fewer employees

who perform sensitive safety- or security-related function,

the rule specifies that only one supervisor is required to

make the determination that would trigger testing of an

employee based on reasonable cause. The FAA also has

clarified the annual EAP training requirements for super-

visors to make it clear that supervisors who make reason-

able cause determinations must have specific training that

will enable them to assess and demonstrate the basis for

testing based on reasonable cause.

Testing after Return to Duty. ATA believes that the

FAA should not set regulatory standards governing post-

rehabilitation testing. ATA, other employer and employee

organizations, and many individual commenters believe

that a schedule for postrehabilitation testing should be

made by management in consultation with persons in-

volved in an employee’s rehabilitation program. In order

to ensure continued disassociation from drugs, RAA sup-

ports a requirement for monthly screening, for 12 months,

after an employee has completed rehabilitation.

APFA believes that a schedule for postrehabilitation

testing should be determined by an employee’s EAP coun-

selor and should be limited to a reasonable period of no

more than one year. AFA states that decisions regarding

testing after rehabilitation should be the responsibility of

the individual treatment facility used by the employee.

FAA Response. The FAA agrees with the commenters

that suggest that unannounced testing during any rehabil-

itation and before an employee returns to duty should be

determined by the persons involved in the employee’s re-

hibilitation program. Decisions regarding the frequency

of testing during any rehabilitation program appropri-

ately lie with those individuals who are familiar with and

involved in any employee rehabilitation program.

Tla

However, unannounced testing after an employee re-

turns to duty is critical to ensure an employee’s continued

disassociation from drugs. The FAA believes that it is

essential to require unannounced testing of employees who

have returned to duty in a sensitive safety- or security-

related position for an employer after failing a drug test

given by an employer or after refusing to submit to a

drug test required by the final rule. This type of testing

is the most effective means of ensuring that an employee

remains drug free while performing commercial aviation

duties. Moreover, once an employee has returned to duty,

the FAA and the employer have a substantial interest in

requiring that employee to be drug free while performing

sensitive safety- or security-related duties in commercial

aviation. Therefore, the FAA has included a provision in

the rule requiring an employer to monitor an employee

who has returned to duty by providing unannounced drug

testing, pursuant to a schedule determined by the MRO,

for not more than 60 months after the employee has re-

turned to duty.

The rule also provides that an employer must conduct

unannounced testing of an individual who is hired to per-

form a sensitive safety- or security-related function after

failing a drug test or after refusing to submit to a drug

test for another employer and who has not previously

been subject to return-to-duty testing. This section of the

final rule addresses situations where an individual fails a

drug test or refuses to submit to a drug test but does not

return to duty for an employer. In this case, any subse-

quent employer would be required to test an individual

for not more than 60 months after the individual is hired

to ensure that the individual is drug free. In the FAA’s

opinion, if an employee failed a drug test given by a pre-

vious employer but returned to duty with that employer

in accordance with the requirements of this final rule, a

subsequent employer would not be required to reevaluate

a prior employer’s return-to-work decision. An employer

would be required to test this individual prior to employ-

72a

ment but would not be required to monitor the employee

after the employee was hired. Pursuant to the final rule,

the medical review officer (MRO) has the discretion to

determine the appropriate level of unannounced testing

for an individual or an employee. The FAA believes that

it is appropriate to allow the MRO to tailor the frequency

of this type of testing to adequately address differences

between individuals, the level and type of drug use, and

any treatment or counseling program.

The FAA notes that the MRO also is required to ensure

that an employee has been tested for drugs, in accordance

with the procedures in the final rule and the DOT pro-

cedures, before being hired or returning to duty. In most

cases, the MRO will not be required to arrange testing

for an employee because the employee will have taken a

drug test as part of any employee rehabilitation program.

However, the MRO must ensure that an individual or

employee has been tested, in accordance with the’ pro-

cedures of Appendix I to Part 121 and the DOT pro

cedures, before the MRO can make a recommendation that

an individual be hired or than an employee be returned to

duty after failing a drug test. In the FAA’s opinion, a

preemployment drug test would suffice to satisfy this re

quirement of the final rule.

Employee Assistance Programs and Rehabilitation. The

FAA sought comment in the NPRM regarding three dif-

ferent EAP options. These options specified the circum-

stances under which an employee would be given the op-

portunity to seek rehabilitation. Option 1 would allow all

employees to seek an opportunity for rehabilitation re-

gardless of how the employee’s drug use was detected.

Option 2 would allow most employees, except those em-

ployees whose drug use was detected as a result of post-

accident testing or testing based on reasonable cause, to

seek an opportunity for rehabilitation. Option 3 would

only allow employees who volunteer to seek rehabilitation

and would exclude all employees whose drug use was de-

73a

tected by any other means. Under all three options, an

employer would not be required to offer an opportunity

for rehabilitation or to provide job security to any em-

ployee who was identified as a drug user on the job.

Employer organizations tend to support the third op-

tion proposed in the NPRM regarding rehabilitation and

reemployment or job security opportunities that should

be offered to employees. Part 121 certificate holders,

as generally noted by ATA, support the third option. For

example, Delta Airlines believes that the most effective

deterrent to drug use is the threat of losing a job. On

that basis, Delta states that mandatory rehabilitation and

an opportunity for continued employment would diminish

the effectiveness of the rule. American Airlines disagrees

with ATA’s position and supports the first option. Fed-

eral Express supports the third option if the FAA man-

dates rehabilitation. The Helicopter Association Interna-

tional (HAI) states that requiring an employer-sponsored

rehabilitation program whenever required testing of an

employee produces a positive drug test result places an

unwarranted burden on the employer. HAI believes that

an employer should have the right to dismiss an employee

if any drug test conducted during employment produces

a positive test result. HAI states that the employer should

have the ability to decide which employees, based on the

‘“‘value” of the employee to the organization, would be of-

fered an opportunity for rehabilitation.

Small Part 135 certificate holders generally state that an

employer should have the right to fire any employee who

uses drugs and feel that an opportunity for rehabilitation

should not be offered to any employee who uses drugs.

These small employers base their position on the potential

liability to the company of rehiring a known drug user,

the expense to the company of holding the employee’s job

open, or replacing an employee on a temporary basis,

during rehabilitation.

74a

The AMA reaffirmed its long-standing support of em-

ployment-based treatment and assistance programs for

employees with alcohol or drug problems. The AMA be-

lieves that the FAA should require an employer to pro-

vide one opportunity for rehabilitation to any employee

who voluntarily enrolls in an EAP and to any employee

who is identified as a drug user through testing.

NTSB generally concurred in the concept of requiring

an employer to provide EAP services to employees. The

NTSB recommended that employers be required to offer

one opportunity for rehabilitation to employees who vol-

unteer for an EAP and for employees who are identified

as drug users through any type of drug testing.

Most small business entities, TEMSCO Helicopters,

Inc. and Overseas Air Transport Corporation for exam-

ple, object to a regulatory provision that would require

an employer to provide job security to an individual en-

rolled in rehabilitation. This objection is based on the

financial burden of keeping a job open for an employee

who is unable to perform his or her duties and the

elimination of an employer’s discretion to fire an em-

ployee who uses drugs. RAA believes that an employee

who has successfully completed rehabilitation, as deter-

mined by the head of the rehabilitation program and air-

line management, should be offered an opportunity to

return to duty. Executive Air Fleet (EAF), a Part 135

certificate holder with 200 employees subject to testing

would support job security for an employee who volun-

tarily sought rehabilitation and who had three to five

years of service with the company. SSA also believes

that an employee’s length of employment may be a rea-

sonable factor to consider when specifying an employer’s

obligation to retain or rehire as employee participating

in rehabilitation. SSA also states that holding an em-

ployee’s job open during inpatient rehabilitation will

greatly complicate small business operations for an un-

known time period. Henson Airlines states that, under

a Fam

75a

its existing program, employees will be fired as a result

of a positive alcohol or drug test. ERA Aviation, Inc.

strongly objects to any Federally-mandated rehabilitation

and rehire requirement. ERA Aviation objects to the

cost of providing EAP services, but more important,

objects to assuming the potential liability problems that

could result from rehiring a known user of illegal sub-

stances even if that employee has successfully completed

a rehabilitation program.

Several small operators, including TEMSCO Helicop-

ters, Inc., object to the requirement to provide an oppor-

tunity for rehabilitation to employees identified as drug

users. Henson Airlines provides an opportunity for re-

habilitation only to employees who voluntarily enroll in

rehabilitation. RAA supports these views. Organizations

such as the American Association of Airport Executives

(AAAE) and ATA believe that an opportunity should

be offered only to employees who volunteer for rehabili-

tation. SSA states that there should be no requirement

that a small business retain or rehire any employee who

tests positive for drugs as a result of any unplanned

drug test, including postaccident or for-cause testing.

ATA believes that limiting rehabilitation and reemploy-

ment to volunteers has the dual effect of making safety

the industry’s highest priority and containing the costs

associated with rehabilitation. AAAEF believes that any

employee who tests positive for drugs should be dis-

missed immediately. AAAE comments that employers

and employees should be free to negotiate broader re-

habilitation and reemployment rights as part of a col-

lective bargaining agreement.

. Labor organizations are strong supporters of broad

EAP opportunities and services. TWU and FEIA be-

lieve that all employees who test positive, regardless of

the reason for testing should be given at least one oppor-

tunity for rehabilitation. FEIA supports the require-

ment for at least one rehabilitation opportunity because

76a

a positive drug test is not proof of impairment on the

job. The Teamsters Union believes that negotiated,

client-specific rehabilitation programs should be avail-

able to employees who volunteer and for employees who

test positive on one occasion. Labor organizations com-

ment that all rehabilitation costs should be paid by the

employer either directly or as part of an employee bene-

fit or insurance package. TWU concurs with this posi-

tion, insofar as it relates to the first positive test result,

unless the employee has engaged in conduct that would

otherwise justify suspension or discharge under an ap-

plicable collective bargaining agreement.

ALPA states that there is no valid reason to limit

access to an EAP only to employees who volunteer for

rehabilitation. Based on experience in the HIMS pro-

gram, only 15 percent of the pilots treated for alcoholism

were self-referred; 85 percent of the pilots were discov-

ered by the union or management, or both. ALPA be-

lieves that rehabilitation should be made broadly avail-

able to any employee who could benefit from an EAP

and that, in some cases, a second opportunity for re-

habilitation may be appropriate. ALPA urges the FAA

to revise the proposed regulation to require employers to

pay the cost of rehabilitation programs that are man-

dated by the regulation.

ALPA believes that traditional EAP techniques that

are tailored to a specific population, such as the HIMS

program, will be more effective in deterring drug use

than the anti-drug program proposed in the NPRM.

During the 15-year period that the HIMS program has

been in effect, 800 pilots have participated in rehabilita-

tion for alcoholism yielding a long-term success rate of

93 percent. ALPA states that the average “off line time”

for pilots involved in the HIMS program is approximately

120 days: 30 days for treatment; 30 days for aftercare

treatment, observation, and processing; and 45 to 60

days for processing of an FAA application. The recov-

ee a ae Tees

77a

ery rate for pilots who particpate in one rehabilitation

opportunity is 85 percent. Of the 15 percent of the

pilots who suffer a relapse after the first treatment,

approximately 50 percent are successfully treated in their

second rehabilitation opportunity.

FAA Response. Most comments regarding rehabilita-

tion deal with the issue of whether, and under what cir-

cumstances, to offer rehabilitation and to provide job

security to an employee and the length of any employee

rehabilitation period. The FAA carefully considered the

various arguments submitted by the commenters on the

issue of EAP services and rehabilitation opportunities

for employees. The FAA understands, and considered,

the arguments raised in defense of broad rehabilitation

opportunities and job security for aviation personnel who

use drugs.

However, the FAA reviewed the two options that in-

cluded provisions providing broad rehabilitation oppor-

tunities and job security to employees whose drug use

was detected through testing under the final rule. Many

of the commenters oppose rehabilitation opportunities

and job security for employees who fail to discontinue

drug use and wait to be detected by testing. The FAA

agrees with these commenters and believes that a strong

message must be conveyed to drug users that the use of

drugs is unacceptable in the aviation industry. The

F‘AA’s primary duty, pursuant to statutory mandate,

is to consider the adverse safety consequences surround-

ing the issue of drug use by sensitive safety- and

security-related aviation personnel. On this basis, the

FAA has determined that employers should not be obli-

gated to offer an opportunity for rehabilitation, or to

provide job security to employees who fail a drug test

or who use drugs on the job. The FAA understands that

broad rehabilitation opportunities and job security for

employees, without regard to the manner of detection of

drug use, may help those employees who are unable to

help themselves. But, the FAA believes that it is incon-

78a

sistent with the agency’s safety responsibilities to pro-

mote the message that drug use in the aviation industry

will be tolerated until an individual’s drug use is de

tected through testing. The FAA believes that it is in-

appropriate to place the agency and an employer in the

anomalous position of allowing any employee who uses

illegal drugs to work in a sensitive safety- or security-

related position and whose drug use may adversely affect

aviation safety. Rather, the FAA believes that it is ap-

priate and consistent with its statutory safety mandate

to prohibit an employee who fails a drug test, who re-

fuses to submit to a drug test, or who uses drugs on the

job from actin gin a sensitive safety- or security-related

position. The FAA is convinced that the comprehensive

testing program of sensitive safety- and security-related

employees, combined with an employee assistance pro-

gram to educate and train all personnel, is consistent

with the statutory duty to promote aviation safety and

will reduce any drug use in the aviation community.

The FAA also carefully reviewed the third option pre-

sented in the NPRM that would provide an opportunity

for rehabilitation and job security to an employee who

admitted his or her drug use and who volunteered for

rehabilitation before being detected through drug testing.

However, in the FAA’s opinion and as noted by the com-

menters, there are several issues related to employee

rehabilitation and retention o~ reemployment benefits

that must be considered in < --lopment of the final rule.

For example, the term “rehabilitation” generally

means the period of time during which an employee is

receiving treatment or counseling for a drug problem.

The length of any rehabilitation period is dependent on

several factors such as the availability and enrollment

period of rehabilitation services, the length and extent

of treatment for the level of use and the type of drug

used, collection and analysis of tests given during re-

habilitation, and the review process that may lead to a

79a

recommendation to return to duty in a sensitive safety-

or security-related position. The term “rehabilitated”

generally means that an employee is determined to be

drug free and, based on the employee’s progress and

prognosis during rehabilitation, the employee may return

to work. The fact that an employee has returned to

work does not mean that the employee is exempt from

follow-up or aftercare treatment and counseling.

The FAA is aware of the wide variety of rehabilita-

tion programs that vary both in the length of treatment

and type of treatment depending on the substance used

and the availability of rehabilitation and treatment serv-

ices. One standard rehabilitation and treatment pro-

gram, generally necessary for those individuals who re-

quire intensive inpatient care followed by outpatient care

and counseling sessions, specifies 28 days of inpatient

care. Other programs may involve shorter periods of

time for inpatient care, may involve outpatient treatment

only, or may involve a combination of inpatient and out-

patient care of varied duration. For example, some

treatment programs may require three to four sessions,

given on two or three nights a week, over a six to eight

week period and followed by less frequent meetings or

counseling sessions. Other treatment programs might in-

volve individual or group counseling sessions on a weekly

basis, over a period of one year or more. An additional

factor that affects the length or treatment or rehabilita-

tion is the availability of private or community services

in a particular area.

The FAA reviewed these variables to determine if a

timeframe for voluntary rehabilitation and job security

could be developed and included in the final rule. The

FAA carefully considered the comments from many avia-

tion businesses that oppose any regulatory requirement

to offer rehabilitation and to retain or rehire any em-

ployee who admits to illegal drug use. The commenters

base their objections on several factors including elimina-

80a

tion of an employer’s discretion to terminate an em-

ployee; undue complication of operations due to poten-

tial extended absences of employees enrolled in rehabili-

tation; and negation of an employer’s ability to tailor

rehabilitation opportunities and job security to a partic-

ular employee population. The most strenuous objections

are based on the substantial and unwarranted burdens,

both administrative and financial, associated with reha-

bilitation and job security for employees. Based on fi-

nancial information submitted by the commenters, it ap-

pears that expenses of rehabilitation and job security

opportunities as proposed would seriously affect large

aviation entities and would probably overwhelm small

companies.

After review of the considerable variables in treat-

ment and the extensive arguments presented by the com-

menters, the FAA concluded that a reasonable accommo-

dation of burdens on employers who may not be able to

absorb employee absences and realistic opportunities for

employee rehabilitation can not be imposed in the ab-

stract. Thus, the FAA does not agree with the com-

menters who state that the FAA should specify an op-

portunity for rehabilitation and the amount of time dur-

ing which an employer is required to provide job security

for an employee enrolled in rehabilitation.

Many employers in the aviation industry currently of-

fer rehabilitation opportunities and job security benefits

to employees. The FAA anticipates that those employ-

ers will continue to offer these opportunities and bene-

fits to employees and that other employers may elect to

include these components in any negotiated employee

benefit package. Because many aviation entities have re-

solved the relative administrative, personnel, operational,

and financial issues that surround employee rehabilita-

tion and job security requirements, the FAA believes

that the aviation industry is able to design appropriate

programs and services for its employees. The FAA be-

ee ee ea ae ae ere

Ron cid Didi sion ar pled a

8la

lieves that, in light of the variables and burdens ad-

dressed above, issues regarding an adequate amount of

time for rehabilitation, an appropriate amount of time

to receive a recommendation to return to duty in a sen-

sitive safety-or security-related position, and job security

matters, are best addressed in the specific employment

context.

Thus, an employer is not required to offer an oppor-

tunity for rehabilitation, to provide job security, or to

provide the resources for rehabilitation to any employee.

At the same time, employers may offer these opportuni-

ties and benefits to employees; the FAA urges employers

to consider the experience of employers who have devel-

oped rehabilitation programs.

The final rule does not prohibit an employer from re-

assigning an employee to a position that does not involve

the performance of sensitive safety- or security-related

duties. The final rule also does not dictate whether an

employee is required or permitted to use vacation time,

sick leave, or leave without pay in order to accommodate

the employee’s time away from his or her sensitive

safety- or security-related position. The FAA believes

that issues such as termination, reassignment, hiring of

temporary employees to fill a position, or policies regard-

ing an employee’s absence from a position, are issues

that are appropriately the subject of employer and em-

ployee negotiation or collective bargaining.

The NPRM did not propose to

This text is long and has been trimmed here. Open the source document for the complete record.

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.

Appendix — Bluestein v. Skinner · 498 U.S. 1083 | Frix